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ABSTRACT
STUDIES ON TYPE I AND TYPE II DNA TOPOISOMERASES FROM
MAMMALIAN MITOCHONDRIA
Jia-Hwei Lin
Old Dominion University
and
Eastern Virginia Medical School
1993
Director: Frank J. Castora, Ph.D.
Mammalian mitochondria contain a unique DNA topoisomerase
I with characteristics of both nuclear and bacterial type I
DNA topoisomerases.

This enzyme, purified from bovine liver,

requires cations as cofactors and possesses optimal activity
at pH 7.0, 37°C and either 150 mM K + or Na+ ions.
nuclear

enzymes

and

different

from

the

Similar to

bacterial

enzyme,

divalent ions such as Ca2+ or Mg2+will stimulate but are not
essential for the enzymatic activity.
Like the nuclear DNA topoisomerase I, the mitochondrial
enzyme is capable of relaxing both negatively and positively
supercoiled DNA.

The relaxation of negatively supercoiled DNA

is directly inhibited by camptothecin and indirectly by mAMSA,

a

DNA

intercalator.

The

relaxation

of

positively

supercoiled DNA is also inhibited by camptothecin, however,
with 10 to 20 fold less efficiency.
Like

all DNA topoisomerases,

the mitochondrial

enzyme

forms a transient enzyme-substrate complex through a phosphotyrosyl covalent linkage.

This linkage was found to be at the

5 ' terminus

break,

of

the

DNA

a

manner

similar

to
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the

bacterial DNA topoisomerase I . Mitochondrial DNA topoisomerase
I slightly cross-reacts with antibody raised against nuclear
DNA topoisomerase I indicating the partial similarity of the
structure of the mitochondrial and nuclear enzymes.
Recognition of the DNA substrate was found to be nonrandom judging from the distinct cleavage patterns

of DNA

cleavage assay results.

Analysis of the sequences around 79

sites

nuclear

cleaved

by

the

and

mitochondrial

enzyme

indicated no consensus sequences, though a preference of T
(43%, P = 0.01) at the -1 position was found.
There were three sites showing a strong preference for
cleavage by this mitochondrial DNA topoisomerase I.
had a G at the -1 position.

All three

Furthermore, these sequences can

form a cruciform structure with distinct features no other
cleavage sequences analyzed so far possess.
Mitochondrial DNA topoisomerase I can bind to both single
stranded and double-stranded DNA with a preference for the
latter.

This preference differs from both the nuclear enzyme,

which has no preference for either forms of DNAs,

and the

bacterial enzyme, which prefers single stranded DNA.
A DNA topoisomerase II has also been partially purified
from calf thymus mitochondria.
presence of ATP.

Two type

This enzyme unknots DNA in the
II DNA topoisomerase-targeting

antitumor drugs, m-AMSA and VM-26, are able to inhibit the
unknotting activity at concentrations above 0.5 /uM.
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Chapter I. INTRODUCTION

A. Background and significance

The topological structures of DNA pose an
problem in regulating cellular functions.

interesting

A standard B form

DNA duplex has a pitch of 10.4 base pairs per helical turn.
A closed circular DNA with 10.4 base pairs per helical turn
has

no

torsional

strain

and

is

called

relaxed.

replication and transcription of genomic DNAs,
helical

During

the double

structure of DNA is subject to conformational and

topological strain resulting in underwound regions falling
behind and overwound regions ahead of the replication fork.
DNA topoisomerases are enzymes that interconvert topological
structures of DNA to facilitate replication, transcription and
other genetic processes by modifying the topological state of
DNA using functions similar to those of scissors and glue.
Topological structures of DNA can be described in part by the
linking number.

The linking number, defined as the number of

times the two strands cross one another, of a relaxed DNA is
termed a°.

DNA species with a linking number lower than a0 are

said to be negatively supercoiled.

A positively supercoiled

DNA has a linking number higher than a°.

Examples of DNA

topoisomerase catalyzed reactions are the interconversion of

1
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supercoiled and relaxed, knotted and unknotted, and catenated
and decatenated DNAs.

DNA topoisomerases can be categorized into two types based
on the mechanism of enzyme action on the substrate DNA.
I DNA topoisomerases break one

Type

strand of the duplex DNA,

passing the unbroken strand through the single-stranded break,
and resealing the broken strand resulting in a change in the
linking number by one unit.

On the other hand, type II DNA

topoisomerases alter the linking number in steps of two by
breaking both strands, unwinding the intact double strands and
resealing the break using the energy generated by hydrolysis
of ATP.

These

organisms,

enzymes

have

been

including prokaryotes,

found

in

such as E.

a variety
coli

of

(1) , M.

luteus (2), viruses, such as bacteriophage T4 (3) , and in the
nuclei and organelles of eukaryotes.

In prokaryotes, E. coli DNA topoisomerase I (& protein)
(1) and DNA topoisomerase II (DNA gyrase)
studied.

(4) have been well

The gene coding for the E. coli. DNA topoisomerase

I has been isolated and designated as topK (5). Top A encodes
a peptide with a molecular weight of 110,000 daltons.
enzyme

acts

as

a monomer

catalytic activity.

and

requires

magnesium

for

This
its

A tyrosine residue in the active site of

the enzyme is responsible for a transient covalent linkage in
the enzyme-substrate intermediate (6).

This linkage is formed

between the hydroxyl group of tyrosine and the phosphate group
2
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at the 5' end of the DNA break.
capable

of

relaxing

In vitro, this enzyme is only

negatively

supercoiled

DNA,

and

its

relaxation activity is inhibited by the addition of single
stranded DNA.

The fact that this enzyme reacts with single

stranded DNA was

demonstrated by

its ability to knot

and

unknot the single-stranded circles of phage fd DNA (7) . Thus,
the preference of this enzyme to relax negatively supercoiled
DNA can be due to the presence of transient single-stranded
DNA regions in negative but not positive supercoiled DNA.

DNA gyrase is composed of a pair of two polypeptides, A2B2,
and catalyzes the negative supercoiling of DNA at the expense
of ATP hydrolysis (4).
supercoiled DNA

It preferentially relaxes positively

in the presence of ATP,

negatively supercoiled DNA without ATP.
catenate and decatenate duplex DNA.

while

it relaxes

It is also able to

The two genes gyrA and

gyrB each of which encodes one of the two subunits of gyrase
have

been cloned.

nalidixic acid

(8)

The A protein,

which

and oxolinic acid

is

sensitive

to

(9), has a molecular

weight of 100,000 daltons; the B protein, which is inhibited
by coumermycin A1 and novobiocin, has a molecular weight of
about

90,000

daltons.

Oxolinic

acid

has

been

proven

to

inhibit both the relaxation and the supercoiling activity of
DNA gyrase.

This

inhibitory effect

indicates that

the A

protein is involved in the cleavage and resealing reaction
(9).

Also,

hydrolysis of ATP requires duplex DNA and

inhibited by coumermycin and novobiocin (10).

is

Therefore, the

3
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B protein is responsible for ATP hydrolysis.
has

activity

on

topoisomerase

its

I # DNA

own

(8) .

gyrase

Like

also

Neither subunit

the

forms

prokaryotic
a

linkage at the 5' end of the DNA breaks.

DNA

phosphotyrosyl

The A protein is

involved in the linkage and makes a four base pair staggered
cleavage (11).

In

higher

organisms,

DNA

topoisomerases

I

topoisomerase II from yeast (12), wheat germ
laevis

oocytes

isolated.

(14),

and

Drosophila

DNA topoisomerases

(15,

and/or

DNA

(13), Xenopus
16)

have

been

from several mammalian cell

lines have also been studied, including those from calf thymus
(17), rat liver (18, 19), and cultured human HeLa cells (20).
The

eukaryotic

prokaryotic

DNA

topoisomerase

counterpart

in

its

I

differs

ability

positively and negatively supercoiled DNAs.

to

from
relax

its
both

Divalent cations

are not required for the catalytic activities of eukaryotic
enzymes,

but they have been shown to stimulate them

(18) .

Several eukaryotic type I DNA topoisomerase genes have been
identified,

and no sequence homology with the prokaryotic

enzyme was found.

In addition, a phosphotyrosyl bond is found

at the 3' terminus rather than the 5' terminus of the DNA
break (21).

Type II DNA topoisomerases in eukaryotic cells and phage
T4 lack the ability to introduce supercoiling,

but they are

able to relax both positive and negative supercoils in the
4
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presence of ATP (22).
functions

as

a

The eukaryotic DNA topoisomerase II

homodimer,

subunits of DNA gyrase (23).
5'

phosphoryl

group

of

which

has

homology

with

both

This enzyme also attaches to the

the

DNA break

through

a tyrosine

residue.

The

transient

covalent

linkage

between

DNA

and

DNA

topoisomerases has been demonstrated by using a phosphoryl
transfer

assay

radiolabeled
enzyme.

(24).

by

nick

The

substrate

translation

and

DNA

is

incubated

uniformly
with

the

Upon addition of denaturants, such as sodium dodecyl

sulfate (SDS), the transient enzyme substrate intermediate is
trapped and is termed the "cleavable complex".

If a covalent

linkage occurs, the radioactive phosphate group will remain
attached to the enzyme after degradation of the DNA with DNase
I.

Thus,

visualized

the enzyme will
by

polyacrylamide

be radiolabeled and

autoradiography

after

gel

by

(SDS-PAGE)

gel

separation

it can
on

be

a

SDS

electrophoresis.

A

conclusion can be drawn that among type I DNA topoisomerases
the covalent linkage to the DNA break is at the 3 f terminus
for eukaryotic enzymes and at the 5' terminus for prokaryotic
enzymes.

However, all type II DNA topoisomerases have been

identified as binding to the 5' terminus of the DNA break.

In

all cases, the amino acid involved in the covalent linkage was
identified as tyrosine.

Mammalian mitochondria contain multiple copies of a single
5
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circular DNA of approximately 16,500 base pairs.

Other than

the displacement (D-loop) region, most of the mitochondrial
genome is double-stranded and supercoiled (25).

The D-loop

region is the location of the replication origin of the heavy
strand and is covered by a variety of the single-stranded DNA
binding proteins (26-28).

Mitochondria and the mitochondrial

genome are capable of self replication and the replication of
mitochondrial DNAs starts with the heavy strand.

The light

strand does not replicate until almost two thirds of the heavy
strand

is

replicated

(29).

This

replication

process

of

circular DNAs generates extra topological tension which must
be relieved to allow the movement of the replication fork to
continue.

A variety

of DNA binding proteins

(26-28,

30)

facilitate the replication of the DNA, stabilize the structure
of the DNA, and maintain the proper topology of the DNA during
replication.

Therefore,

the

existence

and

topoisomerases

in mitochondria are important

role

of

issues.

DNA
DNA

topoisomerases in mitochondria would be likely candidates to
participate
Furthermore,
replication

in the replication processes
the
and

separation
the

of

maintenance

the
of

mentioned

circular
the

proper

above.

DNA

after

degree

of

supercoiling at various stages of the cell cycle are other
obvious functions of DNA topoisomerase in mitochondria.

In 1979, Fairfield et al. (31) reported the existence of
DNA

topoisomerase

I

activity

in

rat

liver

mitochondria.

Intramitochondrial DNA topoisomerase I activity has also
6
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been found in mouse L cells (32) and Xenopus laevis oocytes
(33).

DNA topoisomerase I in calf thymus mitochondria has

been identified and isolated by Lazarus et al. in 1987 (34).
The existence of DNA topoisomerase I in human mitochondria has
been further substantiated by Kosovsky and Soslau (35) using
human platelets, which do not contain nuclei.

A

type

II

DNA

topoisomerase

activity

has

also

been

observed in the mitochondria of rat liver cells (Castora et
al., 1982)

(36) and human leukemia (HALL) cells (Castora et

al., 1985) (37).

From the kinetoplasts of the Trypanosomatid

Crithidia fasciculata, Melendy and Ray (38) have purified a
mitochondrial type II DNA topoisomerase.

This purified enzyme

is capable of ATP-dependent catenation and decatenation of
kinetoplast DNA networks as well as catalyzing the relaxation
of

supercoiled

obtainable

DNA.

tissues,

However,
no

due to

mammalian

topoisomerase II has yet been purified.

the

limitations

mitochondrial

of
DNA

Moreover, no other

detailed studies of mitochondrial DNA topoisomerases have been
performed.

In addition to the DNA topoisomerases mentioned above,
various DNA topoisomerases with similar or distinct catalytic
properties

have

also

been

found.

In

plants,

a

DNA

topoisomerase I has been partially purified from an extract of
spinach

chloroplasts

prokaryotic

DNA

(39).

This

topoisomerase

I

topoisomerase
in

its

resembles

requirement

7
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for

magnesium

ions

supercoiled

and

DNA.

its

Another

relaxation
type

I

of

DNA

only

negatively

topoisomerase,

DNA

topoisomerase III, has been identified from E. coli (40) and
has enzymatic properties similar to DNA topoisomerase I.
archebacterium

Sulfolobus

gyrase was isolated.

acidocaldarius

(41),

a

From

reverse

This enzyme utilizes ATP hydrolysis to

introduce positive supercoils into DNA at a reaction
temperature of 75°C.

Under certain conditions DNA topoisomerases can function
as strand-transferases by sealing the enzyme-attached strand
to a strand of another DNA substrate (42).

There are also

enzymes, whose normal function is DNA strand transfer, which
can catalyze DNA topoisomerization.

Examples of this class of

enzymes includes the gene A protein of phage 0X174 (43), the
gene 2 protein of phage fd
product

(44), the phage lambda int gene

(45), and the resolvases Tn3 and yS of transposons

(46, 47).

The existence of multiple DNA topoisomerases and

enzymes with similar activities in one cell is evidence that
the degree of supercoiling of DNA is regulated constantly
during the life cycle of a cell.

The nuclear DNA topoisomerases have been found to be the
target of a number of anti-tumor drugs either in vitro or in
vivo.

Camptothecin,

a

plant
the

Camptotheca

acuminata,

is

selectively

inhibits

the

alkaloid

only

activity

isolated

antitumor
of

drug

eukaryotic

8
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from
which
DNA

topoisomerase

I

(48).

Treatment

of

S-phase

cells

with

camptothecin causes fragmentation of the chromosomal DNA (49),
induction of sister chromatid exchanges (50), retardation in
both RNA synthesis and DNA replication (51) and cell death.
However,

camptothecin

has

no

effect

on

prokaryotic

DNA

topoisomerase I.

Differing from type I enzymes,

DNA topoisomerase II is

targeted by a variety of antitumor drugs, which can be divided
into two categories, DNA intercalators and nonintercalators.
Among the DNA

intercalators,

acridines

(52),

e.g.

m-AMSA,

anthracyclines (53), e.g. adriamycin, actinomycin D (54) and
ellipticines

(55)

have

been

extensively

studied.

Epipodophyllotoxins (56), e.g. VM26, and isoflavonoids, e.g.
genestein, are nonintercalators.
camptothecin,

these

DNA

Similarly to the effect of

topoisomerase

II

poisons

provoke

sister chromatid exchanges and cause chromosomal aberrations.
These type II enzyme inhibitors also cause blockage of cell
mitosis in late S and G2 phases (57).

As mentioned earlier, the activity of bacterial DNA gyrase
is

inhibited

including

by

antibiotics.

novobiocin

and

They

coumermycin

are
Al,

including nalidixic acid and oxolinic acid.

the
and

coumarins,
quinolones,

Of the type II

enzyme poisons, all except m-AMSA exhibit inhibitory effects
on bacterial DNA topoisomerase II.

However, the DNA

topoisomerase II from the Crithidia fasciculata kinetoplasts
9
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was inhibited in vitro by m-AMSA, VP16-213 and VM-26 (58) and
Shapiro

et

al.

(59)

demonstrated

in

vivo

drug-promoted

cleavage of kinetoplast DNA minicircles.

The

mechanism

topoisomerases

of

antitumor

activity

has

drugs

been

in

inhibiting

investigated.

DNA
DNA

intercalators inhibit the relaxation activity of the enzyme by
intercalating

into the

enzyme to the DNA.

DNA preventing the

binding

of

the

Non-intercalators inhibit the resealing

action of the enzyme resulting in the breakage of the DNA.
However, not all the DNA intercalators are able to inhibit the
enzyme

activity which

interfere with

the

suggests

that

function of DNA

these

drugs

directly

topoisomerases.

This

theory is based on the fact that ethidium bromide, even though
it is a strong intercalator,

shows no antitumor activity.

Besides,

an

o-AMSA,

which

is

analogue

of

m-AMSA

and

intercalates DNA as well as m-AMSA, has much weaker antitumor
activity (60).
al.

(60)

This leads to a hypothesis made by Nelson et

stating that the formation

of a drug-enzyme-DNA

ternary complex is a key step in the inhibitory effect of
drug. Furthermore, some DNA topoisomerase II inhibitors, such
as the coumarins, may act by competing with ATP for binding to
the enzyme.

By interfering with the breakage-resealing reaction of DNA
topoisomerases, these antitumor drugs stabilize the "cleavable
complex" which results in the breakage of the DNA.
10
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Use of

these drugs has helped in the detailed study of the mechanism
of the enzymes.

A DNA cleavage assay based upon the formation of cleavable
complexes showed that nuclear DNA topoisomerases cleaved DNA
in a nonrandom fashion (61, 62).
drugs

strongly

stimulates

the

The presence of antitumor
cleavage

reaction

inhibitors even generate new DNA cleavage sites.

and

some

Though no

consensus sequences were identified, a preference for T at
position -1 to the cleavage site was observed and a loosely
defined 5 base pair sequence
eukaryotic

DNA

topoisomerase

(-4 to +1)
I.

For

was

revealed for

prokaryotic

DNA

topoisomerase I, a preference for C at the -4 position was
derived,

even

though

poly(dT),

poly(dC)

and

short

homo-oligomers of all four nucleotides can be cleaved by the
enzyme (63).

A specific cleavage sequence for human DNA topoisomerase
I has been identified by Westergaard and coworkers (64), and
DNA topoisomerase I preferentially relaxes supercoiled DNA
containing
indicates

a
the

sequence
cleavage

of

5 /-AAAAAAGACTT*AGAAAAATTTT-3/

site)

(65).

Shuman

identified

(*
a

pentameric sequence motif (C/T)CCTT as a specific DNA cleavage
site by Vaccinia virus DNA topoisomerase I (66) .

The lack of

a definite consensus sequence for DNA cleavage leads to the
suggestion that the conformation of the DNA may play a role in
recognition by DNA topoisomerases.

Using single stranded-DNA,

11
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cleavage has been shown to occur in the regions capable of
base pairing
similar

(67).

Shen et al.

in 1989 concluded that a

local twist angle occurs

in over

one hundred DNA

topoisomerase I cleavage sites analyzed (68).
single

theory

is

able

to

explain

how

DNA

Up to now, no
topoisomerases

recognize their substrate DNA.

B. Statement of problem

Much has become known about the DNA topoisomerases

in

nuclei and in bacteria, but few detailed studies of mammalian
mitochondrial DNA topoisomerases have yet been performed.

The

purpose of this project is to study the function and role of
mammalian

mitochondrial

DNA

topoisomerases.

Since

mitochondria are the power factories of the cell, the quantity
of mitochondria

in each cell is controlled by the

requirements of the cell.

energy

The effects of the mitochondrial

DNA topoisomerases on the replication and transcription of the
mitochondrial genome indirectly affect the metabolism of the
cell.

Studies on these mitochondrial enzymes will help us

understand the regulation of the mitochondrial genome as well
as the relationship between the mitochondria and the whole
cell.

Two types of DNA topoisomerases, Type I and Type II, will
be isolated and purified for enzyme characterization.

In

enzyme characterization, the optimal reaction condition for
12

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

the enzymes will be investigated.

The physical properties,

such as the molecular weight, the K,,, value, and the V,^ of the
enzymes will be determined.

The interaction of the enzymes with the substrate DNA will
be studied.
cleaves

Whether the mitochondrial enzyme recognizes and

DNA

in

investigated.

a

random

or

nonrandom

fashion

will

be

Furthermore, the existence of a covalent bond

in the cleavable complex and the determination of the covalent
binding site as either at the 3' terminus or 5' terminus of
the DNA break will be pursued.

Any preferential binding in

substrate DNA structures and sequences by the mitochondrial
enzyme also falls within the scope of this study.

Although reports have demonstrated the inhibition of the
catalytic activity of nuclear topoisomerases and kinetoplast
DNA topoisomerase II by a variety of antitumor drugs, there
have

been

no

similar

topoisomerases.
the

reports

for

mammalian

mitochondrial

One of the goals for this study is to test

sensitivity of these mitochondrial

enzymes to various

antitumor drugs.

These studies will help researchers to understand the
function of mitochondrial DNA topoisomerases and hopefully to
distinguish
counterpart.

the

mitochondrial

enzyme

from

its

nuclear

This may have an impact on our understanding of

the role these enzymes play in mitochondrial biogenesis.
13
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The

characterization of their behavior towards the antitumor drugs
may

influence our development of successful therapies

cancer and/or other pathological conditions.

14
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for

Chapter II. MATERIALS AND METHODS

A. Materials

Plasmid pUC19 DNA was isolated from HB101 cells harboring
the plasmid by lysing the cells with alkaline-SDS followed by
cesium chloride centrifugation in the presence of ethidium
bromide.

The P4 phage and its host cells were gifts from Dr.

Leroy Liu.

The P4 knotted DNA is isolated from the protocol

listed in the appendix I.

Mitochondrial DNA was recovered

from the purified bovine liver mitoplasts. Taq DNA polymerase
was purchased from Perkin-Elmer/Cetus.

EcoRI,

Hindlll and

Nick translation system (cat # 8160SB) were from Gibco BRL.
All other restriction enzymes and fmol DNA sequencing system
were purchased from Promega.
was

a

kind

college,

N.Y.

phosphate,
DNA

gift

radioactive

Dr.

Y.

Tse-Dinh,

Camptothecin,,

m-AMSA,

New

York

VM-26,

Medical

Cellulose

hydroxylapatite, phenyl agarose, double stranded

cellulose

threonine,

from

Bacterial DNA topoisomerase I

were

from

Sigma.

Phosphoserine, phospho-

and phosphotyrosine were also from Sigma.
nucleotides,

including

[gamma-32P] ATP

All
(3000

Ci/mmol) , [a-32P]dCTP (400 Ci/mmol) and [3H]dTTP (10 Ci/mmol)
were purchased from New England Nuclear.

DNA grade agarose,

acrylamide and bis-acrylamide were from Fisher.

All other

15
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chemicals were of analytical grade or higher.

B. Equipment

E-C 103 power supply by E-C Apparatus Corporation was used
for

agarose

gel

electrophoresis.

Both

MBP

3000D

Electrophoresis power supply and DNA sequencing system by IBI
were used for DNA sequencing.
station,

Stratagene pressure control

Posiblot apparatus, and Stratagene UV stratalinker

1800 were used for DNA transfer.
UVP,

UV transilluminator was from

Inc.

The camera system was an MP-4 Land camera from

Polaroid.

LKB Ultrascan XL enhanced laser densitometer was

used for scanning gels.
Savant

speed-vac.

DNA samples were concentrated in a

concentrator

refrigerated condensation trap.
was used for gel drying.

connected

to

a

Savant

A Biorad model 83 slab dryer

DNA primers were synthesized in a

Cyclone DNA synthesizer by Biosearch, Inc.

C. Methods

Protein determination;

Protein was measured by biuret analysis (69) at the early
stages of purification and by the method of Bradford
after the column chromatography.

(70)

Bovine serum albumin was

used as standard protein in either procedure.

16
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Marker enzvme assays:

Glucose-6-phosphate
succinic dehydrogenase,

dehydrogenase,
amine

sulfite

oxidase,

oxidase and DNA polymerases

alpha and gamma were assayed essentially as described in (71).
The

amount

of

polymerase

beta

and

gamma

activity

that

contributed to the alpha polymerase assay was determined by
performing

an

alpha

polymerase

This

corrected

aphidicolin.

assay

in

activity,

the
pol

presence
alpha',

of
was

calculated from the following equation:
pol alpha' = pol alpha (total) - pol alpha (plus
aphidicolin)
and

was

used

to

calculate

the

ratio

of

gamma

to

alpha

polymerase in the final preparation.

Isolation of DNA topoisomerases:

Nuclear DNA topoisomerase I was purified from the calf
thymus according to the published procedure (72).

Mitochondrial DNA topoisomerase I was either purified from
the calf thymus by the previously published procedure (34) or
from the bovine liver by the modified procedure

listed in

appendix II.

Mitochondrial DNA topoisomerase II was purified as stated
below.

The mitochondria, mitoplasts and the inner membranes
17
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were

isolated

essentially

published procedure (34).

as

described

in

the

previously

A protease inhibitor cocktail (1 mM

of PMSF, 0.7 mg/L of pepstatin A, 0.5 mg/L of leupeptin, 1 mM
of sodium sulfite, 0.5 mM of EDTA, 1 mM of 2-Mercaptoethanol)
was

included

mitoplasts.
7.3.
in

in

all

steps

after

lysis

All potassium phosphate

of

the

purified

(KPi) buffers were pH

The inner membranes were solubilized with Triton X 100
150

mM

KPi

/

1.0

M

NaCl

/

20%

glycerol

and

mitochondrial DNA was removed by polyethylene glycol
precipitation.

the
(PEG)

After centrifugation, the PEG-supernatant was

diluted with 20% glycerol to 0.33 M NaCl and loaded on a
phosphocellulose column equilibrated with 50 mM KPi / 0.33 M
NaCl / 20% glycerol.

After washing with three bed volumes of

starting buffer, the enzyme was eluted with 50 mM KPi / 0.8 M
NaCl

/ 20% glycerol.

Active fractions were

combined and

loaded directly on a hydroxylapatite column equilibrated with
50 mM KPi / 0.8 M NaCl / 20% glycerol.

After washing with

this starting buffer and three bed volumes of 0.2 M KPi / 20%
glycerol, the enzyme was eluted with a single step of 0.5 M
KPi / 20% glycerol.

The active fractions were dialyzed into

storage buffer (0.5 M KPi / 50% glycerol) and kept at -20°C.

DNA topoisomerase assay:

Standard DNA topoisomerase I relaxation assay:

Standard

DNA topoisomerase I activity was measured by the extent of
relaxation of supercoiled pUC19 DNA as described by Lazarus et
18
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al.

(34) .

One unit of relaxing activity removes 50% of the

supercoils from the substrate in 30 minutes at 30°C.

Relaxation of positively supercoiled DNA assay:
pUC19

DNA

was

generated

by

treatment

with

Relaxed

nuclear

DNA

topoisomerase I under standard assay conditions and recovered
by phenol
bromide

extraction and ethanol precipitation.

(4 jug/ml)

generate

the

was

added

positively

to the

supercoiled

relaxed

Ethidium

pUC19

substrate

DNA to
for

DNA

topoisomerases. After the 30 min incubation, the reaction was
stopped by 0.1 M EDTA and the ethidium bromide was removed by
phenol extraction.

The removal of the ethidium bromide from

the relaxed DNA generates negatively supercoiled DNA.
conversion

of

the

relaxed

pUC19

DNA

into

the

The

negatively

supercoiled DNA indicates the relaxation of the positively
supercoiled DNA by DNA topoisomerase.

DNA topoisomerase II assay: P4 unknotting assay was used
to measure DNA topoisomerase II activity as described (73).
One unit of activity converts 50% of the knotted DNA into
unknotted monomer at 30°C in 30 min.

PCR amplification:

The sample contains 10 n 1 of 5X Taq buffer

(83 mM of

(NH4)2S04, 33 5 mM of Tris-HCl (pH 8.8), 33.5 mM of MgCl2, 50 mM
of J3-mercaptoethanol, 850 /il/ml of bovine serum albumin, and
19
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34 fiM of EDTA) , 3 jil of

25 mM each

dNTP,

25 pmol

oligonucleotide primer, 5

/xlof DMSO, and 250 ng of template

DNA in a final volume of 50 /xl. After addition of 5
Tag polymerase and 25 /zl

each of

units of

of paraffin oil, the samples were

placed in an automatic thermocycler and incubated at 94°C for
6 minutes,

28

cycles

of 94°C for

30 seconds,

53°C for 30

seconds, and 65°C for 2 minutes, and a final extension at 65°C
for 7 minutes.

The amplified samples were kept at 4°C until

further analysis.

Uniquely end-labelled DNA substrate:

Using PUC19 plasmid DNA as substrate;

Plasmid pUC19 was

linearized with Eco RI and radiolabeled at the 5' end using T4
polynucleotide kinase and [gamma-32P]ATP, followed by Hindlll
restriction digestion to generate a substrate with only one
strand radiolabeled.

Using PCR amplified bovine mitochondrial DNA as substrate;
One

primer

was

polynucleotide

radiolabeled
kinase

and

at

the

5'

[gamma-32P]ATP.

end

using
The

T4
PCR

amplification protocol described above was employed with 10
pmoles of each primer.

20
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DNA cleavage assay;

Uniquely end-labelled DNA substrate (5 ng) was incubated
with DNA topoisomerase I (40 to 200 units)
minutes

in

standard

topoisomerase

assay

at 37°C for 15

condition

in the

presence of 25 pM. of camptothecin unless otherwise noted.

The

reaction was stopped with addition of SDS (final concentration
0.5%) and digested with proteinase K (final concentration 0.5
mg/ml) at 55°C for at least 30 minutes.
saturated

phenol

was

added to

An equal volume of TE

extract

the

protein.

For

separation on agarose gel electrophoresis (2% agarose, 60 V,
5 hours) , 3 fil of alkaline stop solution was added.

For

separation by denaturing PAGE (6% or 8% polyacrylamide, 7.5 M
urea, 250 V, 4 hours), 20 pi of sequencing stop solution was
added.

The

gel

was

dried

under

vacuum

and

analyzed

by

autoradiography.

DNA cleavage with exonuclease III degradation assay;

This protocol is the same as the DNA cleavage assay except
for

the

addition

of

exonuclease

III

minutes) before proteinase K digestion.

(65

U,

37°C

for

30

Uniquely end-labelled

PCR amplified DNA was used as substrate and the assay products
were separated on denaturing PAGE.
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DNA cleavage with Klenow extension assay:

The standard DNA cleavage assay was performed with non
radiolabeled DNA substrate.

Klenow DNA polymerase (1 Unit)

and [a-32P]dCTP (2 /iCi) was added and incubated at 37°C for 3
minutes before proteinase K digestion.

The assay products

were separated on denaturing PAGE.

DNA cleavage with T4 polynucleotide kinase phosphorylation
assay:

Standard

DNA

cleavage

radiolabeled DNA substrate.

assay

was

performed

with

non

T4 polynucleotide kinase (1 unit)

and [gamma-32P]ATP (1.25 /iCi) was added and incubated at 37°C
for 30 minutes

before proteinase K digestion.

The

assay

used.

The

products were separated on denaturing PAGE.

PCR sequencing:

The

reaction kit

11fmol”

from Promega

was

reaction mixture A includes 50 ng of template DNA, 5 /il of 5X
fmol buffer, 2 pmol of 32P labeled primer, 1 /il of sequencing
Taq in a total volume of 17 /il.

Four /il of mixture A was

added to 1 /il each of dNTP/ddNTP.

The samples were cycled as

follow: 95°C for 2 min, 30 cycles of 95°C for 30 sec, 42°C for
30 sec, and 70°C for 1 min.

Five /il of sequencing stop was
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added and kept at 4°C.

The samples were heated at 95°C for 5

min immediately before loading to a sequencing gel.

Nick-translation of PPC19 DNA with fa-32PldATP or ra-32P1dCTP:

The

pUC19

DNA

was

nick-translated

using

the

nick-translation kit purchased from GIBCO BRL. Radiolabeled
DNA was

recovered by ethanol precipitation.

The DNA was

dissolved in TE and stored at -20°C.

Phosphorvl transfer assay:

The procedure followed was essentially that of Chow et al.
(24) . Nick-translated pUC19 DNA (100 ng) was the substrate in
the

topoisomerase

assay.

One

to

two

hundred

units

of

topoisomerase were added to a final incubation mixture of 200
jLtl•

After

30

minutes

at

30°C,

an

equal

volume

of

20%

trichloroacetic acid was added, the precipitate was collected
by centrifugation and washed twice with

ice cold acetone.

Forty fil of DNase I (0.1 mg/ml in topoisomerase assay buffer
containing 5 mM CaCl2) was added and incubated for 30 minutes
at 37°C.

The reaction was stopped by the addition of an equal

volume of SDS-polyacrylamide gel loading buffer.

The samples

were boiled for 3 minutes and applied to a 10% discontinuous,
SDS-polyacrylamide gel.

23
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Thin laver chromatography for phosphoamino acids analvsia;

This procedure basically followed the phosphoryl transfer
assay.

The solution was dried under vacuum after DNase I

digestion and digested at 110°C in 5.6 N HC1
nitrogen gas.

The samples were dried again and separated on

a silica gel TLC plate.
Butanol

sealed under

: NH3 : H20

=

The solvent mixture was Ethanol :
4

: 1

: 2

: 3

(v/v/v/v) .

After

development of the plate for 5 hours at room temperature, the
hydrolyzed

products

were

visualized

by

ninhydrin

and

the

phosphorylated amino acids were visualized by autoradiography.
Autoradiography was performed for a proper length of time at 70°C using an intensifying screen.

Southern Hybridization:

The DNA samples in the agarose gel were transferred to a
nylon membrane using a posiblot apparatus under 75 mmHg for 45
to 60 min.

The DNA was UV linked to the membrane by using a

Stratalinker at 120,000 /iJ/cm2 for 30 sec.

The membrane was

prehybridized in 5X SSPE at 42°C for 1 hour followed by an
overnight hybridization at the same temperature in 0.5% SDS,
5X SSC, 5X Denhardt solution, 0.1 mg/ml salmon sperm DNA, 50%
deionized

formamide,

and

25 to

50 ng/ml

probe

DNA.

The

membrane was washed as follows before exposure to an X-ray
film: 30 min twice in 2X SSPE/0.1% SDS, 30 min twice in 0.2X
SSPE/0.1% SDS, and 1 min once in 2X SSPE.

Autoradiography was
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performed at -70°C using an intensifying screen.
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Chapter III. RESULTS

A. Mitochondrial DNA topoisomerase I

1. Purification of the enzvme

The type I mitochondrial DNA topoisomerase was purified
from bovine liver by a procedure which was an adaptation of
the previously published method for purification from calf
thymus (34).

The procedure was modified because mitochondria

in bovine liver contain more enzymes and proteins than those
in the thymus in order to support the detoxification function
of the liver.

Higher protease activity has also been observed

in the liver (74).

In order to minimize proteolysis and to

avoid the nonspecific aggregation of proteins,

a modified

procedure for purifying DNA topoisomerases was developed.

The mitochondrial DNA topoisomerase I has been shown to be
a 78,000 dalton protein (p78)

(34).

A 63,000 dalton protein

(p63) was constantly copurified with the topoisomerase I from
the previous preparation procedure (34).
that

the

conditions

p78

and

p63

of high salt

form

a

one

to

It has been shown
one

complex

(0.3 M KCl), whereas

under

the complex

dissociates at a lower salt concentration (0.1 M KCl)
26
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(75).

As demonstrated by Chow
transfer

assay,

DNA

et. al.

topoisomerases

(24) using a phosphoryl
are the

only

proteins

phosphorylated when radiolabeled DNA is used as a substrate.
These enzymes form a covalent enzyme-substrate complex, termed
a

"cleavable

complex". Degradation

by

DNase

I

of

[32P]-radiolabeled DNA of the enzyme-substrate complex results
in a radiolabeled enzyme.
phosphoryl

transfer

Figure 1 shows the result of a

assay

using

the

mitochondrial

DNA

topoisomerase I purified from calf thymus using the previously
published procedure (34).

A radiolabeled p78 was seen in lane

2, which contained the copurified p63 visualized by silver
stain in lane 1.

Due to the low yield of the enzyme, the p78

was not visible by the silver stain.

To

verify

topoisomerase

whether
I

or

the

not,

p63
an

is

the mitochondrial

immunoblot

experiment

antibodies against nuclear enzyme was conducted.
cross-reactivity with

antibody raised against

DNA

using

A slight

nuclear

DNA

topoisomerase I was seen in the very faint band at the 78,000
dalton

position

indicating

the

(lane

d

in

similarity

Figure
of

mitochondrial and nuclear enzymes.

2)

the

of

the

structure

immunoblot
of

the

The p63 protein did not

cross react with the anti-nuclear topoisomerase I antibody.
Hence, the p63 is not a mitochondrial DNA topoisomerase I and
does not possess the DNA relaxation activity.

Based on the fact that p63 dissociates from p78 at low
27
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Figure 1. A result of a phosphoryl transfer experiment.

Lane

1, silver stained result of mixture of p63 and
p78; lanes 2 through 4, results of phosphoryl
transfer experiment; lane 2, treatment of p63 and
p78; lane 3, plus BSA but no enzyme added; lane 4,
treatment of nuclear DNA topoisomerase I.

The

number on the left indicates the molecular weight
of the protein standard used.
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Figure 2. A result of immunobloting with anti-nuclear DNA
topoisomerase I antibody. Lanes a through c , the
silver stained result of the SDS-PAGE of the
samples.

Lanes d through f, the visualization of

the immunoblot with rabbit anti-nuclear DNA
topoisomerase I antibody.

Lanes a and d, a

fraction containing the mitochondrial p78; lanes b
and e, purified p63; lanes c and f, nuclear DNA
topoisomerase I.
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salt

concentrations,

the

purification

mitochondrial topoisomerase

procedure

I was modified.

for

the

The detailed

protocol is listed in Appendix II and is briefly summarized
below.

The

bovine

liver

was

ground

and

homogenized

in

mitochondrial isolation buffer (MIB) and a crude mitochondrial
suspension was collected by differential centrifugation.

The

crude mitochondria were further purified by sucrose gradient
ultracentrifugation.

The purified mitochondria were treated

with digitonin to strip off the outer mitochondrial membrane,
thereby eliminating residual cytoplasmic contaminants.

In the previously published procedure of isolation from
calf thymus, the mitochondrial enzyme was extracted from the
fractured membranes after the cycles of freezing and thawing
of the mitoplast at high salt concentration.

This step is

omitted in this modified protocol and is replaced with direct
lysis

of

the

mitoplasts

by

addition

of

the

non-ionic

detergent, Nonidet P40, at low salt concentration (0.1 M KCl)
so as to maintain interactions between the mitochondrial DNA
(mtDNA)

and mtDNA binding proteins.

mtDNA-protein

complexes

by

After collecting the

ultracentrifugation,

the

DNA

topoisomerase I was extracted from the complex with a high
ionic strength buffer

(1.0 M KCl).

No DNA topoisomerase I

activity was detected in the 0.1 M KCl supernatant.
M

KCl

enzyme

phosphocellulose,

extract

was

then

hydroxylapatite

cellulose columns, sequentially.

and

The 1.0

chromatographed

on

double-stranded

DNA

For details see Appendix II.
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The purity of the mitochondrial preparation was assessed by
the ratio of DNA polymerase gamma (the mitochondrial matrix
enzyme

responsible

polymerase

alpha

for

(the

mtDNA

nuclear

replication)
polymerase

chromosomal DNA replication).

to

the

DNA

responsible

for

A ratio of at least 30

: 1

serves as an

indicatorof mitochondrial origin (33,

ratio of 69

: 1 wasobtained

34).

A

in the 1.0 M enzyme extract

fraction, indicating the mitochondrial origin of the purified
enzyme.

The
purified

change

in

isolation

mitochondrial

stability.

DNA

procedure

yielded

topoisomerase

I with

a

highly

a

longer

Figure 3 shows the result of a silver stain of the

purified enzyme on the SDS-PAGE.

A single band above the BSA

standard was seen on the gel in lane e, which consisted of the
purified mitochondrial topoisomerase I eluted from the double
stranded

DNA

cellulose

SDS-PAGE

is

evidence

column.
of

The

thepurity

lack
of

the

of

the

p63

in

mitochondrial

topoisomerase I resulting from the improved procedure.

2. Catalytic properties of the enzvme

The

optimal

reaction

conditions

for

the mitochondrial

enzyme were investigated in the hope of distinguishing it from
the

nuclear

enzyme.

Figure 4

shows

the

effect of

pH,

temperature and concentration of KCl on the mitochondrial DNA
topoisomerase I relaxation activity.

Figure 4A indicates pH
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Figure 3. The result of a silver stain of the purified
mitochondrial DNA topoisomerase I on the SDS-PAGE.
Lane a, a fraction containing purified bovine liver
mitochondrial DNA topoisomerase I from a double
stranded DNA cellulose column.

Lane b, a fraction

without enzyme activity from a double-stranded DNA
cellulose column.

Lane c, combined active fractions

from a hydroxylapatite column.
active fractions

Lane d,

combined

from a phosphocellulose column.

Lane e, high salt extract, S2

(see Appendix II).

Lanes f and g, bovine serum albumin.

Lane h, high

molecular weight SDS-PAGE standard.
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Figure 4. The effect of pH, temperature, and concentration
of KC1 on mitochondrial DNA topoisomerase I
relaxation activity.

Panel A

shows pH

effects,

panel B shows temperature effects, and panel C shows
effects of KC1 concentration.

The results represent

the average of five or six assays.

The standard 40

mM Tris-HCl assay buffer (pH = 7.0) was used in all
assays except otherwise noted.
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7 as being the optimal buffering condition for the relaxation
activity.

Figure

temperature

4B

is 37°C.

shows

that

the

optimal

reaction

Figure 4C suggests that the maximal

relaxation activity of the mitochondrial DNA topoisomerase I
is found at 200 mM KC1.

These results are very similar to

those for the nuclear DNA topoisomerase I (72).

Earlier studies of nuclear DNA topoisomerase I showed that
magnesium ions are not essential for the enzymatic activity
but will

stimulate

theenzyme activity

(18).

These

same

studies also showed that nuclear DNA topoisomerase I can use
any cation to replace monovalent ions.
of divalent ions on the mitochondrial

Therefore, the effect
enzyme was studied.

Figure 5 shows the stimulation of the mitochondrial enzyme
activity by both magnesium and calcium ions at a concentration
of 2.5 mM.

The results also indicated that the enzyme can use

any cation as a cofactor; either monovalent ions (K+ or Na+)
or

divalent

ions

(Mg2+

or Ca2+) alone could

produce

the

relaxation activity while in the absence of any cations there
was

no

enzyme

activity.

Hence,

there is

no

significant

difference in the catalytic properties of mitochondrial and
nuclear enzymes with respect to cation requirements.

A

further

approach

to characterize the

mitochondrial

enzyme is to determine its kinetic properties,

the maximal

velocity

Analysis of

(V,,^) and the Michaelis constant, K,,,.

the kinetic data was often complicated by the fact that a
34
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Figure 5. The effect of divalent ions on the relaxation
activity of the mitochondrial DNA topoisomerase I.
Panel A shows the effect of CaCl2 on the enzyme
activity.

Panel B shows the effect of MgCl2 on

the enzyme activity.

The same concentrations of

the divalent ions were added to the same lane in
both panels and no monovalent ions were added in
all samples.

Mitochondrial DNA topoisomerase I

was added to all but the control samples.
and b, pUC19 DNA only as control.
no divalent ions added.

Lanes a

Lanes c and d,

Lanes e through t, the

duplicate results of addition of 2.5, 5, 7.5, 10,
15, 20, 25, and 30 mM of divalent ions,
respectively.

I,

supercoiled

relatively relaxed pUC19 DNA.

pUC19

DNA.

Ir,

I0 and II, completely

relaxed and nicked pUC19 DNA, respectively.
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sizable fraction of the starting supercoiled DNA had to be
enzymatically relaxed before the relaxed DNA could be detected
by

staining with

points

(before

approach

using

ethidium bromide,

10

minutes)

which made

difficult

to

early time

obtain.

Southern hybridization with

a

A

new

radiolabeled

pUC19 DNA probe to detect small amounts of relaxed DNA allowed
determinations at very early time points.
example of this experiment.

Figure 6 shows an

Using this method, the relaxed

DNA could be detected at three or four minutes after the
incubation with the enzyme as compared to 10 or 15 minutes of
the normal assay.

The intensities of the bands were scanned

by laser densitometry and analyzed with the aid of a computer
program which allowed quantification of the amounts of relaxed
and substrate DNA at each given time points.

Then, the amount

of the product generated could be calculated by multiplying
the total substrate used with the percentage of relaxed DNA
formed.

The reaction rate is equivalent to the formation of the
product

from substrate under assumptions that the reverse

reaction between the enzyme and the product is negligible and
a

rapid

exists.

equilibrium

between the substrate

and

the

enzyme

Hence, the reaction rate can be derived by dividing

the concentration of the product by the length of time of the
assay.

Under the same assay conditions, the initial reaction

rates were obtained at various substrate concentrations for
both nuclear and mitochondrial enzymes.

A Lineweaver-Burk

36
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Figure 6. An autoradiograph of a southern hybridization of
mitochondrial DNA topoisomerase I relaxation
assay.

The guantity of pUC19 DNA used is indicated

on the top of each set of lanes.

Lanes labeled 0

has only the pUC19 DNA.

Lanes labeled 3' and 4' are

relaxation

for

reactions

3

and

4

minutes,

respectively.
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plot was used to determine the V,^ and K,,, from the obtained
data.

Figure 7 is an example of this plot and the summarized

results for mitochondrial and nuclear DNA topoisomerase I are
shown

in

Table

I.

As

seen

in Table

I,

the

of

the

mitochondrial enzyme is 132.1 pM/min, which is approximately
4 times larger than that of the nuclear enzyme.

Also, the K,,,

of the mitochondrial enzyme is 2.36 nM, which is more than
five times over that of the nuclear enzyme.

These results

suggest a higher affinity for DNA substrate by nuclear enzyme.
However,

further

studies

are

needed

to

verify

these

differences in V,,^ and K,,, because the data obtained for the
nuclear enzyme reflects a single determination.

3.

Requirement for and effect of high energy carriers on

enzyme activity

Although no ATP is required for the activity of type I DNA
topoisomerases, ATP has been shown to inhibit the enzyme (76) .
Since mitochondria are generators of the high energy carriers
in

cells,

it

is reasonable to assume

that

the

level

and

activity of the mitochondrial enzymes is controlled by the
concentration of high energy carriers.

Hence, the effect of

ATP, ADP, AMP, and NAD+ on the mitochondrial topoisomerase I
was investigated.

It was found that both ATP and ADP, at a

concentration lower than 1 mM, have no effect on the enzyme
activity

(Figure 8),

while almost 50% reduction in enzyme

activity was seen at both 2 mM of ATP and 2 mM of ADP.
38
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A

Figure 7. A Lineweaver-Burk plot of the mitochondrial DNA
topoisomerase I kinetic result.
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Table I.

The kinetic constants of type I DMA topoisomerases
V,™ (pM/min)

K™ (nM)

Mitochondrial DNA
topoisomerase I

132.1 ± 11.5*

2.36 ± 0.21*

Nuclear DNA
topoisomerase I

30.5b

0.43b

a, Average value of three trials, r2 = 0.9868.
b, Value from one trial, r2 = 0.9744.
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Figure 8. The effect of ATP and ADP on the relaxation
activity of the mitochondrial DNA topoisomerase I.
Panel A shows the effect of ATP on the enzyme
activity.

Panel B shows the effect of ADP on the

enzyme activity.

The same concentrations of the

ATP and ADP were added to the same lane in both
panels and mitochondrial DNA topoisomerase I was
added to all but the control samples.

Lanes

a through c, pUC19 DNA only as negative controls.
Lanes d through f, plus enzyme only as positive
controls.

Lanes g through u, the triplicate results

of addition of 0.25, 0.5, 1, 2, and 4 mM of ATP or
ADP, respectively.

I, supercoiled pUC19 DNA.

relatively relaxed pUC19 DNA.

Ir,

I0 and II, completely

relaxed and nicked pUC19 DNA, respectively.
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complete inhibitory effect was seen at 4 mM of both ATP and
ADP.

Neither AMP nor NAD+ had an inhibitory effect on the

mitochondrial enzyme up to a concentration of 4 mM (data not
shown). These results are similar to those of nuclear enzymes
(76) .

4. Antitumor drug effect on the enzvme activity

The activity of type I DNA topoisomerase isolated from
bovine liver mitochondria is shown in Figure 9 to be inhibited
by camptothecin, a plant alkaloid previously shown to target
the nuclear type I topoisomerase in mammalian cells (48).

In

Figure

9,

the

effect

of

camptothecin

topoisomerase I relaxation activity is seen.

on

the

DNA

Shown in Figure

9A, in the absence of this drug, approximately two units of
mitochondrial DNA topoisomerase I activity can convert almost
all of the substrate DNA from the negative supercoils into the
relaxed

form

relaxation

is

increased.

A

camptothecin

(lanes

b

and

inhibited as
substantial
(lanes

m

c);

however,

the amount

of

the

extent

of

camptothecin

is

inhibition occurred at

and

n)

and

essentially

2 /nM of
complete

inhibition was effected by 25 /iM of camptothecin (lanes q and
r).

A similar profile was obtained with the nuclear enzyme

(Figure 9B).

During replication and transcription, the movement of the
42
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Figure 9. The effect of the antitumor drug, camptothecin, on
the DNA topoisomerase I relaxation activity.

The

antitumor drug was dissolved in DMSO and added to
the assay mixture to make a final concentration of
5% DMSO.

Panel A is the result of the treatment of

mitochondrial enzyme.

Panel B is the result of

the treatment of the nuclear enzyme.

The same lanes

in both panel have the same treatment.

Lane a,

pUC19 DNA only as a negative control. Lanes b and c,
plus enzyme only as positive controls.

Lane d,

another positive control with enzyme and 5% of DMSO.
Lane e through v, duplicate assay results from the
addition of the following concentrations of
camptothecin: 0.2, 0.4, 1, 2, 5, 10, 25, 50, 125
lM, respectively.

I, supercoiled pUC19 DNA.

relatively relaxed pUC19 DNA.

Ir,

I0 and II, completely

relaxed and nicked pUC19 DNA, respectively.
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replication and the transcription enzyme complexes along the
DNA duplex can create significant torsional stress because of
the

accumulation

replication

fork

of

positive

supercoils

or

transcription

in

bubble.

front
The

of

the

need

for

release of this stress is evident and can be accomplished by
the action of a type I topoisomerase.
of

camptothecin

topoisomerase
examined.

on

I to

the

ability

relax

of

positively

Therefore, the effect
the

mitochondrial

supercoiled

DNAs

DNA
was

Figure 10 shows the results of this experiment.

The positively supercoiled pUC19 DNA (lane a) was generated by
intercalating the relaxed pUC19 DNA with ethidium bromide.

If

the mitochondrial DNA topoisomerase I was functioning as the
nuclear

enzyme,

the

positively

relaxed by the enzyme.

However,

supercoiled

DNA

would

be

by removing the ethidium

bromide from the enzyme-treated sample with phenol extraction,
the DNA would become negatively supercoiled.
lane

b.

This

relaxation

activity

is

This is seen in
unaffected

by

concentrations of camptothecin lower than 10 /iM (lanes d-f)
but is reduced as more camptothecin is added (lanes g-j).

The above result shows that it requires approximately 10
to 20-fold more camptothecin to achieve the same level of
inhibition

in

relaxing

positive

supercoils

as

it

did

to

inhibit relaxation of negative supercoils (compare lanes i and
j in Figure 10 with lanes m and n or o and p in Figure 9).
The unexpected difference in the camptothecin concentration
requirement for the mitochondrial enzyme prompted further
44
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Figure 10. The effect of camptothecin on the relaxation of
positively supercoiled DNA by both mitochondrial
and nuclear DNA topoisomerase I.

Lanes a through

j, mitochondrial enzyme-treated samples.
through t, nuclear enzyme-treated samples.

Lanes k
Lanes

a and k, relaxed pUC19 DNA only as a negative
control.

Lanes b and 1, plus enzyme only.

Lanes

c and m, plus enzyme and 5% DMSO as a positive
control.

Lanes d through j, plus camptothecin at

at concentrations of 2.5, 5, 10, 20, 40, 80 and
160 fiM, respectively.

Lanes n through t, the same

as lanes d through j.
Ir, relatively

relaxed

I, supercoiled pUC19 DNA.
pUC19

DNA.

I0 and

II,

completely relaxed and nicked pUC19 DNA,
respectively.
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investigation to

study the effect

of camptothecin

on the

ability of the nuclear DNA topoisomerase I to relax positively
supercoiled DNA.
nuclear

Lanes n through t in Figure 10 show that the

topoisomerase

I

exhibited

the

same

level

of

sensitivity toward camptothecin as the mitochondrial enzyme
did.

The antitumor drug m-AMSA, which has been shown to target
the nuclear topoisomerase II, was also found to inhibit the
mitochondrial type I DNA topoisomerase relaxation activity
(Figure 11) .

It can be seen that m-AMSA at 5 /xM (lanes i and

j) begins to inhibit mitochondrial topoisomerase I relaxation
activity,

and at

a concentration of

completely inhibited (lanes o and p ) .

25 fiM

the

enzyme

is

Note that the pattern

of inhibition caused by m-AMSA (Figure 11) is different from
that of camptothecin (Figure 9).

Since m-AMSA is known to

intercalate into DNA, this inhibition could be due either to
a direct

inhibition or

interaction with the mitochondrial

enzyme or to the intercalation of the drug into the DNA which
causes a change in the DNA conformation.
experiments

were

conducted

in

order

The following two
to

determine

mechanism causes the inhibitory effect of m-AMSA.
the

DNA

cleavage

assay

and

the

relaxation

of

which

They are
positively

supercoiled DNA in the presence of m-AMSA.

The DNA topoisomerase-targeting antitumor drugs have been
proven to stabilize the enzyme-substrate cleavable complex by
46
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Figure 11. The effect of type II DNA topoisomerase targeting
antitumor drugs, m-AMSA, on mitochondrial DNA
topoisomerase I relaxation activity.

The m-AMSA

was dissolved in DMSO and added to the assay
mixture to make a final concentration of 5% DMSO.
The result shows a decrease in enzyme activity as
the concentration of m-AMSA increases.

Lanes a

and b are negative controls with pUC19 DNA only.
Lanes c and d are positive controls with the
enzyme only.

Lanes e and f are positive controls

with the enzyme and a final concentration of 5%
DMSO.

Lanes g through t are duplicate assay

results in the following concentrations of m-AMSA:
2.5, 5, 7.5, 10, 25, 50, 100 /iM, respectively.
I, supercoiled pUC19 DNA.
pUC19

DNA.

I0 and

II,

Ir, relatively relaxed
completely

relaxed

and

nicked pUC19 DNA, respectively.
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inhibiting the resealing ability of the enzymes

(61).

The

direct interaction of DNA topoisomerases with the antitumor
drugs should result in the trapping of an enzyme-substrate
cleavable complex and subsequent degradation of the substrate
DNA.

Using a DNA substrate with only one end radiolabeled on

one strand (uniquely end labeled), the degraded DNA fragments
can be separated and observed on a denaturing gel.
and

13

show

the

results

of

cleavage

assays

Figures 12
affected

by

camptothecin and m-AMSA.

Using uniquely end labeled pUC19 DNA as substrate,
effect

of

camptothecin

on

both

nuclear

and

mitochondrial

topoisomerase I-induced cleavage is seen in Figure 12.
very

little

camptothecin

DNA
in

cleavage
both

was

nuclear

mitochondrial topoisomerase I

seen

without

(lanes

c

the

No or

addition

through

(lanes i through k)

e)

of
and

cleavage

assays, while the addition of camptothecin greatly stimulated
the cleavage of the DNA substrate (lanes f through h and 1
through m ) . Figure 13 compares the effect of camptothecin and
m-AMSA on the cleavage assay.
lower

strand

of

H-ORI

Lanes c through f show that the

(see definition

in

section

5)

was

cleaved by the mitochondrial topoisomerase I in the presence
of camptothecin at concentrations ranging from 2.5 to 25 /liM.
A similar profile would be expected if the inhibitory effect
of m-AMSA was due to the trapping of the enzyme-DNA cleavable
complex.

As

seen

in

lanes

i

through

1,

the

m-AMSA

concentrations between 2.5 to 25 fXi/l does not stimulate
48

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

in

Figure 12. An autoradiograph showing the effects of
camptothecin
mitochondrial

on
DNA

DNA

cleavage

topoisomerase

by
I.

nuclear

and

Linearized

uniquely end-labeled pUC19 DNA was used as
substrate.
contains

Lane a is a labelled DNA only.
labelled

DNA

and

25

Lane b

/iM camptothecin.

Lanes c through e are the result of the assay using
10, 20, and 40 units of nuclear DNA topoisomerase
I without camptothecin.

Lanes f through h are the

same as lanes c through e with 25 juM camptothecin.
Lanes i through k represent the results of the
assay using 25, 50 and 75 units of mitochondrial
DNA topoisomerase I without camptothecin.

Lanes 1

through n are the same as lanes i through k with 25
/nM camptothecin.
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2
3
4

Figure 13. A DNA cleavage assay showing the DNA was cleaved
in the presence of camptothecin but not mAMSA.
Forty units of mitochondrial DNA topoisomerase I
was used in all but control samples.

The lower

strand radiolabeled H-ORI was used as substrate.
Lanes a, b, g, and h, amplified H-ORI DNA only.
Lanes c, d, i, and j, with 2.5, 5, 10, and 25 yM. of
camptothecin, respectively.

Lanes e, f, k, and 1,

with 2.5, 5, 10, 25 yM. of m-AMSA, respectively.
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cleavage of DNA by the mitochondrial enzyme.

Since these

concentrations of m-AMSA have been shown to completely inhibit
mitochondrial DNA topoisomerase I relaxation activity

(see

Figure 11), this lack of cleavage indicates that the m-AMSA
does not trap a cleavable complex intermediate during the
reaction catalyzed by the mitochondrial enzyme.

To further support this conclusion, the effect of m-AMSA
on the ability of the mitochondrial DNA topoisomerase I to
relax positively supercoiled DNA was investigated.
inhibition of relaxation of negatively

If the

supercoiled DNA by

m-AMSA observed earlier was the result of an intercalation of
the

drug

into

the

substrate

DNA,

the

use

of

positively

supercoiled DNA would decrease the availability of sites for
drug intercalation, thereby decreasing the inhibitory effect
of the m-AMSA.

Figure 14 shows the inability of the m-AMSA to

inhibit the relaxation of positively supercoiled DNA as the
DNA

substrate

bromide.

As

has
in

already
Figure

9,

been
the

intercalated
relaxation

by

of

ethidium

positively

supercoiled DNA is indicated by the presence of negatively
supercoiled

DNA

in the

gel

(lane b).

In

Figure

14

the

addition of as much as 250 juM m-AMSA has no inhibitory effect
of the production of negatively supercoiled DNA.

Thus,

in

contrast to the results with negatively supercoiled DNA (see
Figure

11),

there

is no

inhibition of

positively supercoiled DNA by m-AMSA.

the

relaxation

of

This result further

indicates that the inhibition observed in Figure 11 is due to
51
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Figure 14. The effect of m-AMSA on the relaxation activity
of positively supercoiled DNA by mitochondrial
DNA topoisomerase I.

Lane a, relaxed pUC19 DNA

only as a negative control.

Lane b, plus enzyme

only as a positive control.

Lanes c through g,

with 12.5, 25, 50, 250 fiM of mAMSA, respectively.
I, supercoiled pUC19 DNA.
pUC19

DNA.

I0 and

II,

Ir, relatively relaxed
completely

relaxed

and

nicked pUC19 DNA, respectively.
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the

intercalation

interaction

of

of
the

m-AMSA
drug

and

not

with

the

due

to

a

specific

mitochondrial

DNA

topoisomerase I.

The effect of the nonintercalator drug VM 26 which targets
type

II

DNA

topoisomerase

was

also

investigated.

No

inhibitory effect on relaxation of negatively supercoiled DNA
by this drug was seen up to concentrations of 50 /xM (data not
shown).

This result indicates that no contaminating type II

DNA topoisomerase is present in the purified mitochondrial
enzyme fraction.

5. Interaction of the enzyme with the substrate DNA

In order to understand how mitochondrial DNA topoisomerase
I interconverts the topological structures of DNA and whether
the mitochondrial enzyme interacts with its substrate DNA in
the

same

way

as

the

nuclear

or

bacterial

enzyme,

the

interaction of the mitochondrial DNA topoisomerase I and its
substrate DNA was investigated.

1.) Identification of the specific interaction sites

In addition to differentiating the direct
effect
results

of

the
of

mitochondrial

antitumor drugs

DNA
DNA

cleavage

or

indirect

on DNA topoisomerases,

assays

topoisomerase

I

also
reacts

reveal
with

the

whether
the

53
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DNA

substrate in a random fashion or at a specific site(s).

The

use of DNA substrates with only one radiolabeled end allows
the

identification

autoradiography,
same

of

the

cleaved

DNA

sites

by

since all fragments visualized contain the

end-terminal

radiolabeled

nucleotide.

Distinctive

patterns of the cleaved DNA would indicate that specific sites
were cut by the enzyme, while a pattern of smeared DNA would
suggest that the enzyme cleaved randomly.

As seen in Figure

12 and Figure 13, the purified mitochondrial enzyme-treated
sample shows distinct cleaved DNA bands using two different
DNA substrates, pUC19 DNA and H-ORI.

This pattern indicates

that the mitochondrial DNA topoisomerase

I recognizes and

cleaves the substrate DNA at specific sites in the same manner
as nuclear enzyme.

Further

examination

of

the

cleavage

patterns

of

DNA

induced by the nuclear and mitochondrial topoisomerase I in
the presence of camptothecin found that both the nuclear and
mitochondrial enzymes cleave pUC19 DNA at almost identical
sites (Figure 12) . All the bands present in the mitochondrial
DNA topoisomerase I treated samples (lanes m and n) are also
visible in the nuclear enzyme-treated samples
There

are

several

enzyme-treated

bands

samples,

which,
are

although

(lanes f-h).

present

significantly

in

both

different

in

intensity, suggesting that there may be some preference for
some

sites

by

either

topoisomerase.

For

example,

bands

labeled 1, 2, 3 and 4 in lane n have higher intensity than in
54
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lane f indicating a preference by the mitochondrial enzyme.
Since the residual amount of uncleaved DNA at the origin is
comparable in both lanes f and n, this result indicated that
an equivalent amount of enzyme activity was present in both
sample treatments.

The previous result suggested the possibility that the
mitochondrial

DNA

topoisomerase

I might prefer

to

act

on

certain DNA sequences and that this sequence preference might
be different from that of the nuclear enzyme.

Experiments

were designed to search for preferential cleavage sites by
mitochondrial

DNA topoisomerase

I.

DNA

sequences

of the

mitochondrial genome would be strong candidates for possible
specific

interactions

topoisomerase.

with

a

mitochondrial

type

I

DNA

DNA fragments from the mitochondrial genome

were used as substrate DNA for a mitochondrial enzyme cleavage
assay.

Three regions of the 16.5 Kbp mitochondrial DNA were

selected based on the involvement of the DNA topoisomerases
with gene replication and transcription.

Regions selected

were the heavy and light strand origins of replication, and
the transcription termination region located at the boundary
of the 12 S ribosomal RNA and leucine tRNA genes.

In

order

to

have

enough

DNA

substrate

for

these

investigation, the polymerase chain reaction was employed to
generate

the

DNA

substrate.

Using

the

published

bovine

mitochondrial DNA sequences and a computer aided program "PCR
55
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Primer Designer”, three sets of DNA primers were selected from
the respective regions mentioned above.

The primers met the

criteria of GC content between 40% to 60%, melting temperature
between 75°C and 85°C, no more than 2 G or C at the 3' end and
no secondary structure.
from

these

primer

Three fragments of DNA were amplified

sets

by

a

multiplex

reaction taking place in a thermocycler.
as H-ORI
strand

polymerase

They are designated

(heavy strand origin of replication), L-ORI
origin

of

replication)

termination region).

and

chain

TERM

(light

(transcription

Figure 15 shows the sequences of these

primers and the length and regions being amplified.

Figures 16 - 18 show the results of DNA cleavage assays
using these three amplified DNAs as substrates.

With the

H-ORI, the cleavage of the upper strand of this 797 bp region
by

both

the

nuclear

and mitochondrial

topoisomerases

was

essentially the same (Figure 16A, lanes b and c). Differences
in

the

intensities

of

the

higher

molecular weight

bands

(labelled 1 and 2) and lower molecular weight bands (labeled
3

-

5)

reflect

topoisomerase used

the

differences

in

in these experiments

the

activity

of

(as judged by the

amount of the residual undegraded,

starting material). The

nuclear

active,

enzyme

was

somewhat

more

resulting

in

a

complete loss of starting substrate and production of small
DNA degradation products.

Furthermore, in Figure 16B, the cleavage of the lower
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Figure

15.

A

representation

of

the

locations

of

the

PCR

amplified DNA fragments on the bovine
mitochondrial genome.

Panel A is a list of the

primer sequences used.

Panel B is a simplified map

of the mitochondrial DNA with the amplified DNA
fragments indicated as different shaded boxes.

The

location and the length of the DNA fragments is
also listed.
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Sequences of the primers used in amplification
of bovine mitochondrial genome.
H-ORI Left: S’-AACCAGAGAAGGAGAACAACTAACCTC-3 *
Right: 5’-GCTCAAGATGCAGITAAGTCCAGCTA-3 ’
L-ORI Left: 5,-ACGACTCACGTATTCTACCACACTA-3,
Right: S’-GAACAAGTCAGTTACCGAATCCTCC-S’
TERM

Left: 5,-TACGACCTCGATGTTGGATCAGGAC-3,
Right: 5’-AAGGAATGCTACGGCCAATAGGATG-39

B.
H-ORI

Cb/

12S

16S

ClUlkly

15691-149

277 4 -3 1 6 0

(797 bp)

(387 bp)

sac;
L-OR

5 1 4 7 -5 9 3 6
(790 bp)

BOVINE MITOCHONDRIAL DNA
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Figure 16. The results of a DNA cleavage assay using amplified
H-ORI DNA fragment as substrate.
strand radiolabelled.
radiolabelled.

Panel A, upper

Panel B, lower strand

The same lanes in both panel have

the same treatment.

Lane a, DNA only.

Lane b,

plus 40 units of nuclear DNA topoisomerase I.
Lane c, plus 40 units of mitochondrial DNA
topoisomerase I.
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strand of the H-ORI by both enzymes gave similar results.
Here again,

the slightly greater amount of nuclear enzyme

results in higher intensity of smaller degradation products
(labeled 5 and 6) and a lower intensity of high molecular
weight bands

(labeled 1 - 4). It should be noted that the

patterns of the cleavage differ along the upper and lower
strands of H-ORI (compare Figure 16A with Figure 16B).

This

result suggests that DNA topoisomerase I can recognize and
cleave both DNA strands.

Figure
cleavage
substrate

17

shows

results

of the L-ORI region.

of

the
This

DNA

topoisomerase

790 bp PCR-amplified

is also degraded by both the mitochondrial

nuclear enzymes in similar fashion.

I

and

The results using upper

strand L-ORI are shown in lanes a through c and the results
using

lower strand L-ORI

are shown in lanes d through e.

Again, there is a slightly greater amount of nuclear enzyme
activity,

hence

a

slightly

greater

intensity

of

lower

molecular weight DNA fragments was seen in lane b compared to
bands in lane c.

However,

the high intensity of the band

labeled 1 in the mitochondrial enzyme treated sample in lane
f suggests that this site may be a preferred site for cleavage
by the mitochondrial enzyme.

The cleavage of the upper and lower strands of the TERM
region is shown in Figures 18A and 18B, respectively.

An

intense band indicated by an arrow in Figure 18A is seen in
59
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Figure 17. The results of a DNA cleavage assay using amplified
L-ORI DNA fragment as substrate.

Lanes a through

c, upper strand radiolabelled.

Lanes d through

f, lower strand radiolabelled.

Lanes a and d,

DNA only.

Lanes b and e, plus 40 units of

nuclear DNA topoisomerase I.

Lanes c and f, plus

40 units of mitochondrial DNA topoisomerase I.
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Figure 18. The results of a DNA cleavage assay using amplified
TERM DNA fragment as substrate.
strand radiolabelled.

Panel A, upper

Lanes a, DNA only.

Lanes

b and c, plus 40 units and 8 units of nuclear
enzyme.

Lanes d and e, plus 40 units and 8 units

of mitochondrial enzyme.
radiolabelled.

Panel B, lower strand

Lanes a and b, DNA only. Lanes c

and d, plus 40 units of nuclear enzyme.

Lanes e

and f, plus 40 units of mitochondrial enzyme.
Panel C, lower strand radiolabelled and
separation on a 12 % denaturing PAGE.

Lanes a

and b, DNA only. Lanes c and d, plus 80 units and
40 units of nuclear enzyme.

Lanes e and f, plus

80 units and 40 units of mitochondrial enzyme.
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the lanes treated with nuclear DNA topoisomerase I.

Due to

the small size (about 100 nucleotides) of this band, the band
intensity could be caused by the higher amount of nuclear
enzymes

in the

preference.
lanes

c

instead of a strong nuclear

enzyme

On the other hand, comparing lanes e and f to

and

fragments

sample

d

in

Figure

18B

(labeled 1 and 2)

indicates

that

at

are clearly produced

greater amounts by the mitochondrial

least

2

in much

DNA topoisomerase

I.

Since the level of starting substrate remaining is essentially
the same in these lanes, suggesting that the amounts of enzyme
activities are closely equivalent, this increased proportion
of bands 1 and 2 probably reflects a stronger preference of
the mitochondrial

enzyme

for these

sites.

Further

study

revealed that more nuclear DNA topoisomerase I was required in
order to produce equivalent amounts of these bands.

Figure

18C shows these results; the DNA fragments were separated in
a higher percentage of polyacrylamide gel to achieve a better
resolution.

In most cases both the mitochondrial and nuclear enzymes
recognize

the

same DNA

sequences

for

cleavage.

However,

several preferred cleavage sequences by either enzyme were
observed

from these

DNA cleavage assay

results.

Further

investigations on these sequences were conducted in order to
understand whether a consensus sequence was recognized by
these enzymes

and what

sequences these enzymes preferred.

These results will be presented and discussed in section 3.)
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Studies of sequence specificity and conformation of preferred
DNA substrates.

2.) Verification and characterization of the transient
covalent linkage

The translocation of the radiolabeled phosphate group from
the DNA substrate to the mitochondrial DNA topoisomerase I in
the phosphoryl transfer assay (see Figure 1) proves that the
mitochondrial enzyme forms a transient covalent linkage to its
substrate as demonstrated in the cases of other type I DNA
topoisomerases.

The polarity of the DNA strand which linked

to DNA topoisomerase I was proven to be at the 3' end of the
DNA break for the eukaryotic enzyme and at the 5' end of the
DNA break for the prokaryotic enzyme (21).

It has been shown

that prokaryotic DNA topoisomerase I from E.

coli

and M.

luteus cleaves substrate DNA to yield a 3' hydroxyl and a 5'
phosphate group to which the enzyme becomes linked.
other

hand,

hydroxyl

and

eukaryotic
a

3'

DNA topoisomerase

phosphate

group

to

On the

I produces
which

it

a

5'

becomes

covalently attached.

In all cases, a tyrosine residue in the

active

enzymes

site

of

the

is

involved

in

the

covalent

linkage.

The amino acid residue in the mitochondrial topoisomerase
I which formed this covalent linkage to the substrate DNA was
determined. After incubating DNA topoisomerases with uniformly
63
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32P-radiolabeled
degrading

pUC19

the

DNA

topoisomerases

in

DNA

with
5.6

M

to

allow

DNase

I,

HC1

at

covalent
and

110°C,

linkage,

digesting
the

amino

the
acids

liberated were separated by thin layer chromatography (TLC).
Figure 19 shows the result of this experiment.

Panel A shows

the visualization of the phosphoamino acids with ninhydrin.
Panel B is the autoradiograph of the same TLC plate.

It is

evident that radiolabeled phosphotyrosine is observed in both
the mitochondrial enzyme (lanes c and d) and nuclear enzyme
(lanes

e and

f)

treated samples.

The material migrating

slightly ahead of the phosphotyrosine

is the

incompletely

degraded oligonucleotide as shown in comparison to lane b
which contains

labeled pUC19 DNA without the treatment of

DNase I and HCl.

Therefore, like nuclear DNA topoisomerase I,

the mitochondrial enzyme has become linked to DNA through a
phosphotyrosine covalent bond.

After establishing a phosphotyrosyl linkage between the
mitochondrial DNA topoisomerase I and its substrate DNA, the
question of whether the mitochondrial DNA topoisomerase I is
covalently

attached

to

the

3'

cleavage site was investigated.
potassium-SDS

precipitation

of

end or

5'

end

of

the

DNA

A common experiment utilizes
the

DNA

topoisomerase-DNA

complex with 3' or 5' labeled DNA to determine to which end of
the cleaved DNA the mitochondrial enzyme was linked.

Using

this approach, a large amount of enzyme is required to react
with substrate DNA in order to yield a significant signal to
64
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Figure 19. Analysis of phosphoamino acids involved in the
covalent linkage between DNA topoisomerase I and
the substrate DNA by thin layer chromatography.
Panel A, visualization of phosphoamino acids by
ninhydrin.

Panel B, autoradiography of the same

TLC plate.

Lane a, nonhydrolyzed mitochondrial

DNA topoisomerase I only.

Lane b, untreated DNA.

Lanes c and d, hydrolyzed mitochondrial DNA
topoisomerase I.

Lanes e and f, hydrolyzed

nuclear DNA topoisomerase I.

Lanes g, h, and i,

200 nmoles of phosphoserine, phosphothreonine,
and phosphotyrosine, respectively.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

65

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

noise ratio.

Ambiguous results were obtained with this method

due to the limited amount of mitochondrial DNA topoisomerase
I could be used.

However, using Exonuclease III in the DNA

cleavage assay this question was answered.

Exonuclease

III

(Exo

III)

is a

3'

->

5'

exonuclease

producing 5' mononucleotides and is specific for dsDNA which
has a free 3' hydroxyl terminus at blunt or 5' overhang ends
or at a nick.

As the diagram in Figure 20 shows, if the 3'

end of the DNA break is free of enzyme attachment, the Exo III
will degrade the DNA strand.

This would alter the migration

rate of the topoisomerase-generated cleavage products upon gel
electrophoresis.

If the 3' end of the DNA break is blocked by

the enzyme, no change in the migration rate of topoisomerase
cleavage products would occur.

The starting DNA band which

has not been cleaved by DNA topoisomerases would disappear due
to degradation by Exo III.

Since the catalytic properties and characteristics of the
mitochondrial DNA topoisomerase I resembled the nuclear enzyme
in many ways judging from data gathered so far, the result of
the Exo III / Cleavage assay was surprising.
treated with the mitochondrial enzyme,

In the samples

evidence of a free 3'

end at the DNA cleavage site was seen (Figure 21) suggesting
that the mitochondrial topoisomerase I becomes linked to the
5 ' phosphate group.

Panel A in Figure 21 shows the result of

a regular DNA cleavage assay using L-ORI with the upper strand
66
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Figure 20. A schematic diagram of Exo III / cleavage assay
which

indicates expected results of a 3'

or 5'

linkage to DNA topoisomerase I.
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radioactive phosphate

K 2 topoisomerase

^

Shortened
Cleavage products

Figure 21.

The results of an Exo III / cleavage assay to
determine the linkage of DNA to the mitochondrial
enzyme.
Panel

Panel
B,

DNA

A,

regular

cleavage

assay

treatment of exonuclease III.
only.
enzyme.

DNA

cleavage
with

assay.

additional

Lanes a and b, DNA

Lanes c and d, plus 40 units of nuclear
Lanes e and f, plus 40 units of

mitochondrial enzyme.

The shortening of the

cleaved DNA fragment, which migrated faster in
the denaturing PAGE is caused by the free 3' end
being degraded by the exonuclease III.
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uniquely end-labeled.

Lanes a and b are control DNA samples

without any DNA topoisomerase added.

Lanes

c and d show

camptothecin stimulated cleavage of the substrate DNA by the
nuclear DNA topoisomerase I.

Lanes e and f show a similar

cleavage pattern using the mitochondrial DNA topoisomerase I.
Panel B in Figure 21 shows the result with the treatment of
Exo III.

In both panels, the DNA cleavage pattern of the samples
with nuclear enzyme added (lanes c and d) closely resemble one
another except for the disappearance of most of the uncleaved
substrate.

Since the nuclear DNA topoisomerase I is known to

become linked to a 3' phosphate when it cleaves DNA (21), the
nuclear enzyme is expected to block the 3' ends of cleaved
fragments, protecting them from Exo III degradation.

Thus it

is expected that the migration rates of nuclear topoisomerase
cleavage fragments should be the same with or without Exo III
treatment.
mechanism,

If the mitochondrial
then

the

migration

enzyme acts
rates

of

by the same

those

cleavage

fragments should also be the same with or without Exo III.
However, the comparison of lanes e and f in both panels shows
that the Exo III treatment has altered the mobility of many of
the bands generated by the mitochondrial DNA topoisomerase I.
These data suggest that the mitochondrial DNA topoisomerase I
is linked to the phosphate at the 5' end of the cleavage site
which would leave a free 3' hydroxyl group on the other side
of the break.
69
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However,

one could argue that the free 3'

end of the

cleavage sites caused by the mitochondrial DNA topoisomerase
I is due to the fact that the mitochondrial enzyme does not
form a covalent linkage as strong as the nuclear enzyme and
that the Exo III or that the reaction conditions for the Exo
III

were

able

to

prevent

the

mitochondrial

permanently attaching to the DNA.
designed

to

variations

test
of

these

the

polynucleotide kinase
Klenow

fragment.

III

/

(T4 PNK)

After

the

from

Two other experiments were

results.

Exo

enzyme

These

two

Cleavage

assay

and E. Coli.
DNA

assays

are

using

T4

DNA polymerase

cleavage

assay,

the

enzyme-substrate complex was subjected to either T4 PNK with
[gamma-32P]ATP or the Klenow DNA polymerase with
treatment.

[a-32P]dCTP

Using T4 PNK, which only phosphorylates the 5'

end of DNA strand, a blockage at the 5' end will be verified
if no or little DNA is radiolabeled.
Klenow

DNA

polymerase,

which

has

a

By the same token,
5'

->

3'

activity and a 3' -> 5' exonuclease activity,

polymerase

could assess

free or blocked 3' ends.

Figure 22 shows a diagram of the reasoning behind this
experimental design.

Shown in the left panel, the Klenow DNA

polymerase will incorporate less radioactive precursor into
DNA fragments cleaved by the nuclear DNA topoisomerases I,
which is covalently bound to the 3' end of each fragment, than
those cleaved by the mitochondrial enzyme,
suggested to form a 5' end covalent bond.

which has been

For the T4 PNK

70
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Figure 22. Schematic diagrams of the reasoning behind the
Klenow / cleavage assay and the T4 PNK / cleavage
assay.
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Mito.

Nuclear KS8

Nuclear

Klenow
Radioactive dCTP

★Radioactive residue

Nuclear topoisomerase I

Mito.

T4PNK
Radioactive ATP

GUDMitochondrial topoisomerase I

/cleavage

experiment,

one would

expect

just

the

opposite

result, with the nuclear enzyme yielding fragments that are
labeled by T4 PNK and [gamma-32P] ATP because they have free 5'
hydroxyl groups.

If the mitochondrial enzyme is covalently

attached to the 5' ends of these fragments then T4 PNK would
not be able to label all the cleaved fragments except the ones
at the 5'ends of each starting substrate DNA.
result in smaller radiolabeled bands.

This would

The incorporation of

radioactivity can be assessed both by scintillation counting
of high molecular weight DNA and by autoradiography after gel
electrophoresis.

These results are presented in Figure 23 and

Figure 24.

Figure 23 shows results of the T4 PNK / Cleavage assay.
Panel A shows the autoradiograph of the separation of the
radiolabeled DNA fragments by denaturing gel electrophoresis.
Without DNA topoisomerase I treatment (lanes a through c ) , the
only radiolabeled band is the substrate DNA.

In the nuclear

enzyme treated samples (lanes g through i), many radiolabeled
DNA bands are seen and the majority of the radiolabeled bands
are large DNA fragments, indicating free 5' ends on these DNA
fragments.

By contrast, in the mitochondrial enzyme treated

samples (lanes j through 1), the radiolabeled bands are either
the starting material or small DNA fragments which are the
result of blocked 5 'ends.

Note in lanes d through f that

addition of camptothecin did not inhibit the incorporation
activity of T4 PNK.

Panel B shows the results of
72
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Figure

23.

The

results

of

a T4

PNK

/ cleavage assay

to

determine the linkage of DNA to the mitochondrial
enzyme.

Panel A shows the electrophoretic results

of this assay.

Lanes a, b and c, DNA only.

d, e and f, DNA with 25 iM camptothecin.

Lanes

Lanes g,

h and i, plus nuclear enzyme and 25 pH of
camptothecin.

Lanes j, k and 1, plus mitochondrial

enzyme and 25 nM of camptothecin.

Panel B shows

the results by scintillation counting.
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B.
Results of scintillation counting of T4 PNK / Cleavage assay
cpm/min

L-ORI

Control

427.5

Nuclear
enzyme

Mito.
enzyme

40 units

40 units

1377.3

567.2

74

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure

24.

The

results

of

a Klenow

/ cleavage

assay

to

determine the linkage of DNA to the mitochondrial
enzyme.

Panel A shows the electrophoretic results

of this assay.

Lanes a, b and c, DNA only.

d, e and f , DNA with 25 fiM camptothecin.

Lanes

Lanes g,

h and i, plus nuclear enzyme and 25 fxM of
camptothecin.

Lanes j, k and 1, plus mitochondrial

enzyme and 25 /xM of camptothecin.

Panel B shows

the results by scintillation counting.
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B.
Results of scintillation counting of Klenow /Cleavage assay
cpm/min

Control

Nuclear DNA
Topoisomerase I
80 units

H-ORI

969.6

142.6

L-ORI

696.6

304.3

TERM

297.2

147.3

40 units

Mitochondrial
DNA
Topoisomerase I
80 units

40 units

N.D.

1971.1

641.7

1511.7

1468.6

336.1

710.8

1122.0

N.D.
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scintillation

counting,

which

clearly

indicates

a

low

incorporation of radionucleotides in the mitochondrial treated
samples.

Both outcomes indicate a blockage of the 5' end of

the DNA break by mitochondrial DNA topoisomerase I.

The results of the Klenow / Cleavage assay are given in
Figure 24.

Again, panel A is the autoradiograph of the gel

electrophoresis and panel B shows the results of scintillation
counting.

As in the experiments with T4 PNK, no inhibitory

effect by camptothecin of radioactive incorporation by Klenow
DNA polymerase was seen (compare lanes d through f to lanes a
through

c).

As

expected

in

the

nuclear

samples,

no or very little DNA was radiolabeled due to the

covalent

linkage of the enzyme to the 3' ends of the DNA

breaks.

On the contrary, a smeared image was seen in the

mitochondrial enzyme treated samples.

enzyme-treated

Klenow DNA polymerase

extended the mitochondrial enzyme-cleaved DNA into various
lengths.

These

results

further

confirm

that

a

free

3'

hydroxyl group was generated by the mitochondrial enzyme.

Thus,

the

above evidence

indicates

that the mammalian

mitochondrial type I DNA topoisomerase resembles the bacterial
enzyme in its linkage to the 5' end of DNA break.
first verification that mitochondrial

DNA

This is the

topoisomerase

I

clearly differs from the nuclear enzyme and establishes the
fact

that

mammalian

mitochondria

maintain

their

own

topoisomerases.
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DNA

3.) Studies of sequence specificity and the
conformation of preferred DNA substrates

The fact that mitochondrial DNA topoisomerase I recognizes
and cleaves DNA in a non-random fashion was presented earlier
(Figure 12).

The immediate question is, what kind of DNA

sequences do the DNA topoisomerases recognize?
this,

sequence

analysis

of

mitochondrial

To answer
and

nuclear

topoisomerase I cleavage sites was conducted by utilizing the
dideoxy-sequencing technique.
around

the

cleavage

To investigate the sequences

sites,

the

DNA

substrates

were

PCR

amplified from bovine mitochondrial DNA with one end-labeled
primer and again used in the DNA topoisomerase cleavage assay.
The

same

primer

was

used

in

four

dideoxy

PCR

sequencing

reactions in reagents provided by the commercially obtained
"fmol

kit"

to

generate

oligonucleotides.

four

sets

of

varying

lengths

of

The products of the sequencing reaction and

the cleavage assay reactions were resolved side by side on a
denaturing polyacrylamide sequencing gel. Figure 25 shows a
typical autoradiographic example of one such gel.

The arrows

indicate the cleavage by DNA topoisomerase I between the two
flanking nucleotides.

Using
identified.

this

process,

Table

II

seventy-nine
lists

20

cleavage

nucleotides

downstream from all of the cleavage sites.

sites

upstream

A detailed

78
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were
and

Figure 25. An autoradiographic example of DNA sequence
analysis of DNA cleavage sites.

The four lanes

designated A, G, C, and T are the dideoxy
sequencing products.

The lanes designated m are

the mitochondrial enzyme-treated DNA cleavage
assay products.

The lanes designated n are the

nuclear enzyme-treated DNA cleavage assay
products.

The arrows indicate the cleavage

sites.
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Table II.
List of all the cleavage sites with both 20
upstream and downstream nucleotides. All sequences are listed
from 5' to 3'. The space between the two sequences indicates
the cleavage site.
Sites from upper strand of the amplified L-ORI
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.

TCCACAAACAACATAAAAAT
CACAAACAACATAAAAATAA
CATAAAAATAAAATGACAAT
TAAAAATAAAATGACAATTT
GACAATTTCCCCTTATGAAA
AATTTCCCCTTATGAAAAAA
CAATAGTCGTATTATCTACC
ATAGTCGTATTATCTACCAT
ATACTATCAGTGTTAGAATA
ACTATCAGTGTTAGAATAGG
TTAATTCCTGATAAGGATTG

AAAATGACAATTTCCCCTTA
AATGACAATTTCCCCTTATG
TTCCCCTTATGAAAAAAATA
CCCCTTATGAAAAAAATAAC
AAAATAACTTTTCTACCAAC
ATAACTTTTCTACCAACAAT
ATAATACTACCACTCACGCC
AATACTACCACTCACGCCAA
GGAATTTAGGTTAAACAGAC
AATTTAGGTTAAACAGACCA
CAAGACTACACCTTACATCA

Sites from lower strand of the amplified L-ORI
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

CCGAATCCTCCAATTATGAT
GAATCCTCCAATTATGATTG
TGGTATTACTATGAAGAAGA
GTATTACTATGAAGAAGATT
TTACTATGAAGAAGATTATT
CTATGAAGAAGATTATTACA
GAAGATTATTACAAATGCGT
AGATTATTACAAATGCGTGT
CGGTTACAACTACGTTGTAG
GTTACAACTACGTTGTAGAT
AATTCAGCGCGAATTAGAAG
TTCAGCGCGAATTAGAAGGC
CCAAATAGTAGATAAAGGGT

TGGTATTACTATGAAGAAGA
GTATTACTATGAAGAAGATT
TTATTACAAATGCGTGTGCG
ATTACAAATGCGTGTGCGGT
ACAAATGCGTGTGCGGTTAC
AATGCGTGTGCGGTTACAAA
GTGCGGTTACAACTACGTTG
GCGGTTACAACTACGTTGTA
ATTTGGTCGTCTCCGAGCAG
TTGGTCGTCTCCGAGCAGAG
GCTTAGAGCTGTTCCTACTT
TTAGAGCTGTTCCTACTATA
ACCAATATCTTTATGGTTGG

Sites from upper strand of the amplified TERM
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.

CAGGACATCCTGATGGTGCA
GGACATCCTGATGGTGCAAC
AAGGTTCGTTTGTTCAACGA
GGTTCGTTTGTTCAACGATT
AAGTCCTACGTGATCTGAGT
TCCTACGTGATCTGAGTTCA
CGTGATCTGAGTTCAGACCG
TGATCTGAGTTCAGACCGGA
TTTCTATCTATTACGTATTT
TCTATCTATTACGTATTTCT
AGGACAAGAGAAATAAGGCC
TTAAATCAAGCGCCTTAAGA
AAGACAACCAATGATAACAT

ACCGCTATCAAAGGTTCGTT
CGCTATCAAAGGTTCGTTTG
TTAAAGTCCTACGTGATCTG
AAAGTCCTACGTGATCTGAG
TCAGACCGGAGTAATCCAGG
GACCGGAGTAATCCAGGTCG
GAGTAATCCAGGTCGGTTTC
GTAATCCAGGTCGGTTTCTA
CTCCCAGTACGAAAGGACAA
CCCAGTACGAAAGGACAAGA
AACTTTAAATCAAGCGCCTT
CAACCAATGATAACATCTCA
CTCAACTGACAACACAAAAC
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Table II. (Continued)
Sites form lower strand of the amplified TERM
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.

GAATAATTAGTATTAAGATG
ATAATTAGTATTAAGATGTT
ATTAGTATTAAGATGTTAAT
TAGTATTAAGATGTTAATTA
TTAAGATGTTAATTATGAAC
AAGATGTTAATTATGAACAT
ATGAACATTTTGTTAAGGAG
GAACATTTTGTTAAGGAGAG
AAAAGTTTAAGTTTTATGCA
AAGTTTAAGTTTTATGCAAT
AGGGTTTTGTGTTGTCAGTT
GGTTTTGTGTTGTCAGTTGA
TTTGTGTTGTCAGTTGAGAT
TGTGTTGTCAGTTGAGATGT
TTGTCAGTTGAGATGTTATC
TCAGTTGAGATGTTATCATT
ATCATTGGTTGTCTTAAGGC
TAATTGGTTGTCTTAAGGCG
CTTGATTTAAAGTTGGCCTT
GATTTAAAGTTGGCCTTATT
CCTTATTTCTCTTGTCCTTT
TTATTTCTCTTGTCCTTTCG
TACTGGGAGAAATACGTAAT
ATACGTAATAGATAGAAACC
ACGTAATAGATAGAAACCGA
AGGACTTTAATCGTTGAACA
AACTAAGCCCTGTTCTAGGG
CTAAGCCCTGTTCTAGGGCA

TTAATTATGAACATTTTGTT
AATTATGAACATTTTGTTAA
TATGAACATTTTGTTAAGGA
TGAACATTTTGTTAAGGAGA
ATTTTGTTAAGGAGAGGATT
TTTGTTAAGGAGAGGATTTG
AGGATTTGAATCTCTGGATA
GATTTGAATCTCTGGATATA
ATTACCGGGCTCTGCCACCT
TACCGGGCTCTGCCACCTTA
GAGATGTTATCATTGGTTGT
GATGTTATCATTGGTTGTCT
GTTATCATTGGTTGTCTTAA
TATCATTGGTTGTCTTAAGG
ATTGGTTGTCTTAAGGCGCT
GGTTGTCTTAAGGCGCTTGA
GCTTGATTTAAAGTTGGCCT
CTTGATTTAAAGTTGGCCTT
ATTTCTCTTGTCCTTTCGTA
TCTCTTGTCCTTTCGTACTG
CGTACTGGGAGAAATACGTA
TACTGGGAGAAATACGTAAT
AGATAGAAACCGACCTGGAT
GACCTGGATTACTCCGGTCT
CCTGGATTACTCCGGTCTGA
AACGAACCTTTGATAGCGGT
CAGGGTTTTGTGTTGTCAGT
GGGTTTTGTGTTGTCAGTTG

Sites from lower strand of the amplified H-ORI
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.

CCGGGTCAGGGCCTTTGACG
ATCAGGGCCTTTGACGGCCA
AAAAATACCAAATGTATGAC
AAAATACCAAATGTATGACA
TTGACAGCACAGTTATGTGT
AGACAGCACAGTTATGTGTG
AGCATGGGCTGATTAGCCAT
GCATGGGCTGATTAGCCATT
AGCTACAATAGATGCTCCGG
CTACAATAGATGCTCCGGGT
AGTCCATCGAGATGTCTTAT
TCCATCGAGATGTCTTATTT
GACCGTTTTAGATGAGATGG
TTTTAGATGAGATGGCCCTG

GCCATAGCTGAGTCCAAGCA
TAGCTGAGTCCAAGCATCCC
AGCACAGTTATGTGTGAGCA
GCACAGTTATGTGTGAGCAT
GAGCATGGGCTGATTAGCCA
AGCATGGGCTGATTAGCCAT
TAGTCCATCGAGATGTCTTA
AGTCCATCGAGATGTCTTAT
GTCAGGGCCTTTGACGGCCA
CAGGGCCTTTGACGGCCATA
TTAAGAGGAAAGAATGGACC
AAGAGGAAAGAATGGACCGT
CCCTGAAGAAAGAACCAGAT
AAGAAAGAACCAGATGCCTG
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examination showed no single recognizable nucleotide at both
ends

of cleavage

several

and no consensus

approaches

were

attempted

sequences.

Therefore,

to

the

analyze

data.

Analysis based on the absolute occurring frequency of each
base suggests a prevalent T (43%, P = 0.01) at the 3' end of
the DNA break.

To determine any consensus sequences flanking

the cleavage site,

base compositions of the DNA fragments,

which are 30.15% for A and T and 19.85% for G and C, were
taken into account.

A sequence was deduced by considering

whether a residue occurred with higher observed base frequency
than

the

expected

base

frequency

relative to the cleavage site.

at

a

certain

position

The resulting sequence

A N A (A / T ) ( A / T ) T T C G A T T T T A G ( G / A )

is

(A/G) GT

*

(A/G)ANNN(T/G)NTNNTGN(G/C)GGCCTA, where N is any nucleotide
and the asterisk indicates the point of cleavage.

However, due to the difference in base compositions each
base has different standard error.

The standard error

is

derived from the expected frequency for a given sample size.
It is calculated by taking the square root of the following
equation:

Expected frequency * ( 1 - Expected frequency)

sample size.

/

Thus, the standard error for A and T would be

V . 3015*(1-.3015)/79 = 0.0516 and the standard error for G and

C would be V . 1985*(1-.1985)/79 = 0.0449.

The upper and lower

bounds of a confidence interval (Cl) are computed by adding to
and subtracting from the expected frequency the standard error
times the appropriate value from the normal distribution.
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For

a 90% Cl, the value is 1.645.

For 95% and 99% CIs, the values

are 1.96 and 2.757.

Figure 26 shows a plot of relative base frequency at all
40 analyzed sites.

The solid horizontal line is the expected

relative frequency and the 90% confidence interval is plotted
as dashed horizontal lines.

When an observed frequency falls

beyond the confidence interval, it is viewed as statistically
different.

This out of boundary frequency indicates that

there is only a 10% chance that this difference between the
observed and the expected relative frequency is the result of
a random sampling error.

The following positions had the

listed favorite nucleotide based on the bases with a relative
frequency higher than the boundary of 90% Cl: positions -1, -7
and -8 for a T, positions -6 and -11 for an A, position +16
for a G and position +17 for a C.

There

is also a very

unfavorable C region ranging from -5 to -11 positions.

This

means very rarely a DNA with C residues at these positions
will result in cleavage of this DNA by DNA topoisomerase I.

Furthermore,

by

considering

the

occurrence

of

purine

versus pyrimidine based on the 90% Cl, a purine rich cluster
was

seen

at

-2

to

-6

region

and

+1

position.

Further

consideration of the composition of AT and GC base pairs at
the same level of Cl found that AT rich regions span from
positions -7 to -11 and positions -15 to -17, a GC rich region
between positions 14 and 17 was also found.

From the above

83

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 26. Plots of confidence levels for each nucleotide
position around a DNA topoisomerase cleavage site.
The

solid

line

in

the

center

is

the

expected

frequency, 30.15% for A and T and 19.85% for G and
C.

A, filled triangle; T, filled square; G, cross

with a plus; C, empty square with a cross.
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analysis,

a general diagram of the sequence around the DNA

topoisomerase

I cleavage

presented in Figure 27.

site

can

be

constructed

and

is

This sequence includes one purine

rich region and two AT rich regions upstream of the cleavage
site, one GC rich region downstream of the cleavage site and
a preferred T at the cleavage site.

The

cleavage

sites

preferred

by

mitochondrial

DNA

topoisomerase I on the lower strand of the amplified TERM DNA
fragment were further analyzed

(Figure 18B bands 1 and 2).

After a detailed examination of these sequences, a departure
from the

conclusion mentioned above was

seen.

All

three

sequences had a G at the -1 position rather than a T and were
able to form a stem-loop structure by base pairing as shown in
Figure 28.

The two stem-loop structures thus constructed have

several similar features.

First, the loop is GC rich and it

starts and ends with a G and a T.

Second, the cleavage occurs

inside the loop at the position close to the center of the
loop.

Third, the stem is formed by an AT rich five base-

paired structure holding together by a total of 11 hydrogen
bonds.

Fourth, two conserved sequences occur at the base of

the stem and they are a TTNT at the left and a T-TGG at the
right.

None of the other cleavage sites with a G at the -1

position

is able to form such a structure with the above

mentioned characteristics.
important

for

the

Thus, this structure seems to be

mitochondrial

DNA

topoisomerase

recognize its substrate for preferential cleavage.
85
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I

to

Figure 27. A diagram of a suggested sequence recognized by DNA
topoisomerase I.
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Figure 28.

A diagram of two proposed cruciform structures
deduced

from mitochondrial

DNA

topoisomerase

preferred sequences.
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4.) Studies of the preferential binding of the enzymes
to certain types of substrate DNAs.

The similarity between the mitochondrial and bacterial DNA
topoisomerase I in the linkage to the 5' end of the DNA break
lead to further investigations in distinguishing between these
two enzymes.

The preferential binding to the single-stranded

DNA by the bacterial E. coli DNA topoisomerase I has been
demonstrated (7).

In addition, nuclear DNA topoisomerase I

showed no preference for either single- or double-stranded
DNA.

Therefore,

topoisomerase

I

investigated.
behavior
single-

of

the
with

Two
the

interaction of the mitochondrial DNA
single-

approaches

mitochondrial

or

double-stranded

were
DNA

and double-stranded DNA.

competition

assays

in the presence

used

to

DNA

was

evaluate

the

topoisomerase
The
of

first

I

toward

approach was

single-

or

double

stranded DNA, and the second approach was DNA cleavage assays
using either single- or double-stranded DNA as substrate.

In the first approach, relaxation of supercoiled DNA was
measured in the absence and presence of both linear single(heat denatured) and double-stranded DNA.

Figure 29 shows a

densitometric tracing of the results of this experiment.

The

linear DNA used in this experiment is a 795 base pair DNA
fragment electroeluted from Maelll restriction digested pUC19
DNA.

Panel

A

shows

that

relaxation

activity

of

mitochondrial enzyme is inhibited in the presence of both
88
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the

Figure 29. Densitometric tracing of the result of a
competitive assay with single-stranded or double
stranded DNA.

Panel A, results from mitochondrial

DNA topoisomerase I treated samples.
results

from the bacterial

treated samples.
plus enzyme.
pUC19-795

DNA

Panel

B,

topoisomerase

Line 1, pUC19 DNA only.

I

Line 2,

Line 3, plus enzyme and 42 ng of

(a 795 base pair fragment from Mae III

digested pUC19 DNA.)

Line 4, plus enzyme and 42 ng

of heat denatured pUC19-795.
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A

MITO.

B

BAC.
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single- and double-stranded DNA as indicated by the appearance
of the supercoiled DNA substrate.

However,

the relaxation

activity of the bacterial enzyme is only inhibited by the
presence of single-stranded DNA (Panel B ) .

A similar result

was obtained when another fragment of pUC19 DNA (a 333 base
pairs

DNA

fragment

also

electroeluted

from

the

Maelll

restriction digested pUC19 DNA) was used as substrate (data
not

shown).

This

result suggests that mitochondrial

DNA

topoisomerase I has no preference for single stranded DNA.

Figure 30 shows the result of the second approach which
compares the cleavage of single- or double-stranded DNA by the
nuclear and mitochondrial enzymes.

As seen in lanes b and c,

the cleavage pattern generated by the nuclear enzyme was the
same when either single- or double-stranded DNA was used.
Yet, a very weak cleavage by the mitochondrial enzyme was seen
in lane f when the single-stranded DNA was used.

This result

implicates a preference for a double stranded DNA substrate by
the mitochondrial enzyme and supplies further evidence that
mitochondrial DNA topoisomerase I is distinct from the nuclear
enzyme.

S.) Properties of mitochondrial DNA topoisomerase I
which differ from those of bacterial DNA
topoisomerase I

It has been well-documented that the enzymatic activity of
90
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Figure 30. A result showing the requirement of duplex DNA as
substrate for the mitochondrial DNA topoisomerase
I cleavage assay.
cleavage assay.

Lanes a through c, regular DNA
Lanes d through f, DNA cleavage

assay with the heat denatured DNA substrate.
a and d,

amplified L-ORI DNA with upper strand

radiolabeled only.
enzyme.

Lanes

Lanes b and e, plus nuclear

Lanes c and f, plus mitochondrial enzyme.
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a

b

c

••

d

e

f

•
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the bacterial DNA topoisomerase I is dependent upon magnesium
ions (1).
require

However, eukaryotic DNA topoisomerase I does not

magnesium

ions

for

activity,

but

its

activity

is

stimulated many-fold in the presence of optimal amounts of
magnesium ions (18) . The stimulating effect of magnesium ions
on mitochondrial DNA topoisomerase I activity was demonstrated
in section 2, catalytic properties of the enzvme.

However,

the difference in the relaxation reaction conditions for the
bacterial

enzyme

and

the

ones

for

the

nuclear

and

mitochondrial enzymes made the comparison of the magnesium ion
effect invalid.

To

illustrate

the

real

differences

in

magnesium

ion

requirements, the same buffer system was used to compare the
effect
enzyme.

of

magnesium
The

difference.

result
Not

ions

on

in

Figure

only does

mitochondrial
31

and

further

the bacterial

bacterial

confirmed

enzyme

the

requires

magnesium ions for its relaxation activity, but also magnesium
ion concentrations of 20 mM completely inhibit the activity.
Whereas, mitochondrial enzyme does not require magnesium ion
for its relaxation activity and is stimulated by magnesium ion
at concentrations up to 20 mM.

The inability of the bacterial enzyme to relax positively
supercoiled DNA was also seen with this buffer system (data
not shown). Furthermore, up to 160 (M of camptothecin was not
able to inhibit the bacterial enzyme relaxation activity on
92

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 31. The effect of the Mg2+ on the relaxation activity
of the bacterial and mitochondrial DNA
topoisomerase I.

Lane a, pUC19 DNA only.

Lanes b

through k, bacterial enzyme treated samples.

Lanes

1 through u, mitochondrial enzyme treated samples.
Lanes b,

c,

1,

and m,

no Mg+2 added,

lanes

f

through k, duplicate results with addition of 2.5,
5, 10, 20 mM of Mg+2.

Lanes n through u,the same

concentrations of Mg+2 as lanes f through k.
supercoiled pUC19 DNA.
pUC19 DNA.

I,

Ir, relatively relaxed

IQ and II, completely relaxed and

nicked pUC19 DNA, respectively.
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negatively supercoiled DNA (data not shown) . These properties
of the bacterial

enzyme clearly differ

from those

of the

mitochondrial enzyme (see Figures 9 and 10).

B. Mitochondrial DNA topoisomerase II

1. Purification of the enzyme

The

discovery

of the knotted P4

phage

DNA

(73)

as

a

substrate for the type II DNA topoisomerase made the detection
of the enzyme much easier.
knotted circular DNA.
intermolecular

The P4 DNA is a 10.5 kilobase pair

Different degrees of the intra- and

knotting

causes

agarose gel electrophoresis.

a

smeared

DNA

pattern

Restriction digestion of the P4

DNA with EcoR I resulted in three fragments of DNA.
unknotted

by

in

DNA topoisomerase

II,

the

P4

DNA

When

becomes

a

relaxed circular monomer and migrates as a single band (data
not shown).

These experiments were conducted to verify that

the purified DNA from P4 phage was knotted P4 DNA.

The P4

knotted DNA was used as substrate to isolate mitochondrial DNA
topoisomerase

II

and

to

characterize

this

type

II

DNA

topoisomerase.

Mitochondrial DNA topoisomerase II was partially purified
from calf thymus mitochondria.

The mitochondria were purified

as described in the previously published procedure (34).

The

purified mitochondria were treated with digitonin to strip off
94
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the outer mitochondrial membrane, thereby eliminating residual
cytoplasmic

contaminants.

The

resulting

mitoplasts

were

subjected to several cycles of freezing and thawing so as to
rupture the organelle; the mitochondrial inner membranes and
associated

mitochondrial

ultracentrifugation.

DNA

were

collected

by

DNA topoisomerase II was released from

the collected inner membrane-mtDNA mixture by treatment with
the

non-ionic

detergent

salt.

The

mitochondrial DNA was removed by polyethylene glycol

(PEG)

precipitation.

Triton X-100

in high

The resulting supernatant was applied to a

phosphocellulose column, and the activity of DNA topoisomerase
II

was

detected

in

front

of

the

mitochondrial

topoisomerase I activity peak with a slight overlap.
fractions
column.

were

combined

and

loaded

on

a

DNA

Active

hydroxylapatite

The fractions with DNA topoisomerase II activity were

pooled and dialyzed against storage buffer and kept at -20°C.

As seen in Table III, the mitochondrial DNA topoisomerase
II has been purified over 3000-fold from the stage of the pure
mitochondria

using

this procedure.

Since

mitochondrial

proteins make up approximately 25% of total cellular protein,
this result represents more than a 12,000-fold purification
relative

to whole

cell protein.

Due to

the presence

of

nuclease activity mitochondrial DNA topoisomerase II activity
was impossible to obtain in the early fractions.

The total

activity in fraction V was considered as the total activity
for the earlier fractions.

The overall yield thus calculated
95
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Table III. Summary of the purification of DNA topoisomerase II
from calf thymus mitochondria.
STEP

I
II
III
IV
V

1

VI

I VII

FRACTION

VOLUME
(ml)

TOTAL
PROTEIN
(mg)

TOTAL
ACTIVITY
(units)

SPECIFIC
ACTIVITY
(U/mg)

FOLD
PURIF.

YIELD
(%)

210

1316

11500

8.7

1

100

PURE MITOCHONDRIA

95

965

11500

11.9

1

100

MITOPLAST

40

197.5

11500

58.2

4.9

100

120

87.7

11500

131

11

100

0.805

11500

14286

1200

100

CRUDE MITOCHONDRIA

DILUTED PEGSUPERNATANT
PHOSPHOCELLULOSE
COLUMN FRACTION

11.5

HYDROXYLAPATITE
COLUMN FRACTION

0.66

0.085

1320

15529

1305

DIALYZED FRACTION

0.26

0.028

1040

37142

3121

Starting material was 945 grams of fresh calf thymus gland.
Preparation of various intermediate fractions and column chromatography
was as described in Materials and Methods.

,m 9 °J

was 9%.

Several marker
purity

of

isolation

the

enzymes were also used to evaluate the

mitochondrial

procedures.

These

preparation
included

throughout

the

glucose-6-phosphate

dehydrogenase, sulfite oxidase (77), succinic dehydrogenase,
amine oxidase and DNA polymerases alpha (78) and gamma (71,
79).

All of the enzyme assays showed an increase

in the

purity of the mitochondria from step to step (Table IV).

As

expected, glucose-6-phosphate dehydrogenase activity decreased
to a very low level in the PEG-supernatant fraction, and the
succinic dehydrogenase activity was high in this fraction.
Moreover, the activities of sulfite oxidase and amine oxidase
decreased significantly.

Finally, a DNA polymerase gamma to

alpha ratio of 78 to 1 in the PEG-supernatant fraction (Table
V) further indicated the mitochondrial origin of this enzyme
(33, 34).

The unknotting activity of this purified mitochondrial DNA
topoisomerase

II

is

demonstrated

in

Figure

unknotting activity requires ATP as cofactor.

32.

This

Without added

ATP (lane b) no conversion of substrate DNA into the monomer
was seen.

However, in the presence of 1 mM of ATP (lane c ) ,

almost all of the substrate DNA appeared as an intense, slower
migrating band.

As the mitochondrial enzyme was diluted, the

intensity of the monomer decreased (lanes d through f ) .
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Table

iv .

Marker enzyme activities in mitochondrial fractions.

Total Activity
(Units)

G-6-P DH
#1

Mitochondria
Mitoplast

348.6

Succinic DH
#2

513

#1

#2

Amine oxidase
#1

#2

Sulfite
Oxidase
#1

|
*2

22176

15456

100.7

1504

221.1

112.6

251

1969

41.0

38.1

0

0

57.2

34.9

42720

10512

Matrix

0

14.7

47760

18711

PEGsupernatant

0

8.8

175680

23571

-

72.5

—

221.6

G-6-P DH: Glucose-6-phosphate Dehydrogenase
Succinic DH: Succinic Dehydrogenase
#1 and #2: Two different preparations of the mitochondrial enzyme.

76.3

36.6

1
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Table V.

DMA polymerase activities in mitochondrial fractions.

Fraction

Polymerase Activity
(units)
alpha

Crude mitochondria

VO
VO

gamma

Ratio
(gamma/alpha)

67

287

Mitoplast

4

72

18/1

PEG-supernatant

1.3

101

78/1

4.3 / 1

Figure 32. P4 unknotting assay of mitochondrial DNA
topoisomerase II in the presence or absence of ATP.
Lane 1, P4 DNA only; lane 2, plus enzyme minus ATP;
lane 3-6 contain serial diluted enzyme plus 1 mM
ATP; lane 3, 1 fil; lane 4, 1/2 /zl; lane 5, 1/4 n 1;
lane 6, 1/8 /xl.

DNA bands labelled M and L are

monomer and linear P4 DNA, respectively.
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2.

Anti tumor drug effect on enzvxne activity

There have

been no previous reports of any purification of the mammalian
mitochondrial DNA topoisomerase II and the effect of enzyme
activities

by

antitumor

drugs

has

not

been

studied.

Therefore, the response of the calf thymus mitochondrial DNA
topoisomerase II to m-AMSA
VM-26

(a

(a DNA intercalating drug)

non-intercalating

drug)

unknotting assay of phage P4 DNA.
of this experiment.
inhibited

by

was

tested

using

and
the

Figure 33 shows the result

The mitochondrial enzyme was slightly

m-AMSA

at

a

concentration

of

0.5

fiM,

significantly inhibited at 5.0 juM, and completely inhibited at
50 /nM.

A similar profile was obtained with VM-26 although the

latter drug was

not

quite

as potent

an

inhibitor

as

the

former.

P4 unknotting assays of purified calf thymus nuclear DNA
topoisomerase II in the presence of m-AMSA and VM-26 resulted
in

similar

comparison

inhibition
of

the

patterns.

effects

of

Figure
antitumor

34

shows

drugs

on

the
both

mitochondrial and nuclear enzyme activity after the amount of
the unknotted DNA generated was quantitated.
suggests

that

the

mitochondrial

enzyme

is

This result
slightly

more

sensitive to both m-AMSA and VM-26 than is the nuclear enzyme.

101

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 33. P4 unknotting assay of mitochondrial topoisomerase
II in the presence or absence of antitumor drugs.
Lane a, P4 DNA only; lane b, P4 DNA plus enzyme
plus 1 mM ATP; lane c, same as lane b minus ATP.
Lanes d through g, same as lane b plus the
indicated amounts of m-AMSA; lane d, 0.5 fM; lane
e,

5 /zM; lane f,

50 fM;

lane q,

h, same as lane g minus enzyme.

150 /zM.

Lane

Lanes i through 1,

same as lane b plus the indicated amounts of VM-26;
lane i, 0.5 fiM; lane j, 5 /zM; lane k, 50 /zM; lane
1, 150 juM.

Lane m,

same as lane 1 minus enzyme.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

E
JZ
9
M -

■o
o
a

<8

102

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure

34.

Response

of nuclear and mitochondrial

topoisomerases to m-AMSA and VM-26.
contained

a

starting

amount

of

type

II

All samples
two

units

of

unknotting activity.
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Chapter IV. CONCLUSIONS AND DISCUSSION

Mammalian mitochondria contain both type I and type II
DNA

topoisomerases

conclusions

of

identification

this
and

judging

from

study.

Here,

partial

the

results

I

describe

purification

mitochondrial type II DNA topoisomerase.

of

a

and
the

the
first

mammalian

This type II DNA

topoisomerase responds similarly to all other type II enzymes
in

its

requirement

of

ATP

for

its

catalytic

activity.

Furthermore, the type II DNA topoisomerase poisons, m-AMSA and
VM-26, inhibit its unknotting activity more readily than its
nuclear counterpart,

starting at a concentration of 0.5 /iM.

Due to the scarce amount of this type II enzyme recovered,
detailed study of this enzyme was not possible.

Modification

of the enzyme isolation and purification procedure

in the

future is needed for further research.

Working with a mitochondrial enzyme is difficult in the
tremendous amount of tissue required to obtain a substantial
amount of purified protein unless it exists in quantity in the
mitochondria.

It is further compounded by the possibility of

nuclear contamination.
assays

have

been

Even though several marker

employed

as

an

indication

of

enzyme

organelle

origin, the uncertainty remains until proven different.
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However, the investigation of the mammalian mitochondrial
DNA topoisomerase I in this study supplies several insights as
to the function of this enzyme.

Not only does its property

differ from the nuclear enzyme in several ways, but it also
behaves differently from the bacterial enzyme.

The modified

purification procedure (Appendix II) yielded a highly purified
and stable enzyme which made these investigations possible.

The differences between the mitochondrial and the nuclear
enzymes can be summarized in three points.

First, the nuclear

DNA topoisomerase I has smaller K,,, and V,,^ values than those
of the mitochondrial enzyme.
higher

affinity

however,
could

This difference

for substrate DNA

by

indicates a

the nuclear

with a lower maximal reaction rate.

explain

the

need

of

more

enzyme,

This result

mitochondrial

enzyme

in

phosphoryl transfer assay to lend an equivalent amount of
radiolabeled

enzyme

as

seen

from

the

faint

band

in

the

mitochondrial enzyme-treated samples (Figure 1).

Second, the mitochondrial enzyme is covalently linked to
the 5' terminus instead of the 3' terminus of the DNA break.
This difference in linkage is a strong indication of a unique
mitochondrial DNA topoisomerase I and disputes the argument
that the detection of this mitochondrial enzyme could be due
to nuclear contamination or that mitochondria contain the same
DNA topoisomerase I as the nuclei do.

In this regard,

the

mitochondrial enzyme behaves the same as the bacterial enzyme,
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further suggesting evolution of mitochondria from prokaryotes.

Third,

the

mitochondrial

DNA

double stranded DNA as substrate.

topoisomerase

I

prefers

As seen in Figure 29, the

mitochondrial enzyme was only able to cleave double-stranded
DNA substrates while the nuclear enzyme functions on both
single- and double-stranded DNA.

This also correlates with

the low affinity for supercoiled pUC19 DNA substrate by the
mitochondrial enzyme since the highly supercoiled DNA has been
known to have several

single-stranded regions,

binding to

which is unfavorable for the mitochondrial enzyme.

In other respects, the mitochondrial and nuclear enzymes
behave similarly.

Both enzymes do not require divalent ions

for their relaxation activity, though either Mg2+ or Ca2+ can
stimulate activity.

Also,

both enzymes are able to relax

positively and negatively supercoiled DNA.

The inhibitory

effect of ATP and ADP on type I DNA topoisomerases has been
reported earlier (76), and the studies performed here draw a
similar conclusion.

Moreover, investigation of the inhibitory

effect of camptothecin, a type I DNA topoisomerase inhibitor,
indicates

similar

mitochondrial

responses

enzymes.

by

The

both

the

inhibitory

nuclear
effect

and

of

the

m-AMSA

suggests that the conformation of substrate DNA is important
in regulating the activity of the DNA topoisomerase I.
intercalated

with

m-AMSA,

the

negatively

supercoiled

When
DNA

becomes relatively positively supercoiled with an increase in
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linking number.

Thus, the number of turns needed to convert

to the relaxed form by the DNA topoisomerase I is decreased.
After removal of the m-AMSA, the relaxed DNA becomes slightly
negatively

supercoiled

and

is

seen

as

a

loss

of

enzyme

activity.

Like the nuclear DNA topoisomerase I, the mitochondrial
enzyme recognizes specific sites along the DNA substrate as
seen from the distinct cleavage patterns (Figures 15 through
17).

These patterns are practically the same for both nuclear

and mitochondrial enzyme, which indicates the recognition of
the same DNA sequences.

However,

the attempt

to

analyze

recognition sequences by both enzymes yielded no consensus
sequences.

However, a preference for T at the -1 position of

the cleavage site and a purine rich region 5' adjacent to the
T is observed by the mitochondrial and the nuclear enzymes.
This preference is in agreement with results obtained from
other systems (80).

Of all the cleavage sequences analyzed, three sequences in
two

regions

identified
sites.

of

lower

strand

as mitochondrial

of

TERM

fragment

DNA topoisomerase

were

I preferred

These sequences have an unusual cleavage of G at the -

-1 position.
which

the

could

These three sequences have sequence elements
lead

to

the

possible

structures with distinct features.

formation

of

cruciform

These features could be a

key recognition structure by mitochondrial DNA topoisomerase
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I since it prefers double stranded region as substrate.

This

result is in agreement to the report by Edwards et al.

(81)

that a palindromic, single stranded DNA sequence near the SV40
origin of replication was cleaved by DNA topoisomerase I after
a

G.

One

point

worth

mentioning

is

that

the

preferred

cleavage sequences by mitochondrial enzyme located at the TERM
fragment

suggests

a role of this

enzyme

in mitochondrial

genome transcription.

Though the mitochondrial DNA topoisomerase I is similar to
the bacterial enzyme in its linkage to the 5' terminus of the
DNA break, it differs from the bacterial enzyme in all other
respects.
enzyme

First, no requirement of Mg2+ for the mitochondrial

relaxation

activity

was

observed.

Second,

the

mitochondrial enzyme can relax both positively and negatively
supercoiled DNA, whereas the bacterial enzyme only relaxes
negatively supercoiled DNA.
not

sensitive

camptothecin.

to

the

Fourth,

Third, the bacterial enzyme is

type
the

I

DNA

topoisomerase

mitochondrial

enzyme

poison
prefers

double-stranded DNA as substrate, while the bacterial enzyme
binds to single-stranded DNA more readily than double-stranded
DNA.

Thus, the mammalian mitochondrion contains its own type I
DNA topoisomerase with characteristics different from both
nuclear and bacterial enzymes.

The role of mitochondrial DNA

topoisomerase I involving transcription of the mitochondrial
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genome is suggested here.

Judging from the in vitro results

that the mitochondrial enzyme has similar catalytic properties
and the response to camptothecin as the nuclear enzyme, it may
also be involved in replication and recombination of DNA as
well as being a target of antitumor drugs in vivo.

Further

studies are required to understand its biological role inside
the mammalian mitochondria.

Such studies might include the

effects of antitumor drugs on mitochondria, analysis of the
compositions and amino acid sequence of this mitochondrial
enzyme, as well as identification of the gene(s) encoding it.
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Appendix I. Isolation of P4 Knotted DNA
a> Titer P4 phage stock using E. coli. strain c2326
1. Grow 50 ml of c2326 in Complete Modified Luria
Broth (CMLB) overnight or at least 8 hours.
2. Prepare 15 % bottom agar in CMLB using 10 cm
diameter petri dishes, about 25 ml each.
3. Prepare 7 % soft agar in CMLB kept at 47 °C.
4. Check OD600 and calculate the concentration of
cells (1 OD = 8 * 1010 cells/ml).
5. Prepare a serial dilutions of P4 phage (PS1) using
P4 diluent.
6. Mix 0.1 ml of diluted P4 phage with 0.1 ml of c2326
in a 15 ml conical centrifuge tubes.
7. Let stand for 20 min at 37°C with loosened caps.
8. Add 3 ml of warm soft agar into each tube, tighten
the cap and invert the tubes several times.
Immediately pour the suspension on top of the
bottom agar and swirl the plate to ensure all the
agar were evenly distributed without bubbles.
9. Repeat step 8 one at a time.
10. Allow the plates to stand at room temperature for
5 min with the cover half covered.
11. Cover the plates and place the plates upside down
in a 37°C incubator for 8 to 16 hours.
12. Count the lysed colonies in the countable plates
and calculate the titer as following:
No. of colonies * dilution factor / 100 = pfu//zl at
that OD.
b> Growth of P4 phage in E. coli. strain C117
Day 1:
1. Grow C117 in 50 ml of CMLB in a 250 ml Erlenmeyer
flask without plug at 37°C with vigorous shaking
overnight but no more than 18 hours.
Day 2:
2. Dilute the overnight culture with 50 ml of fresh
CMLB and allow to grow for additional 1 hour.
3. Check the O D ^ and calculate the cell
concentration.
4. Add 1 *107 pfu of P4 phage stock to total of
2 * 109 cells (1 fil of P4 phage stock from Dr. Liu
to 10 ml of 1.2 OD overnight diluted culture).
5. Allow to stand at room temperature for 10 min for
the cell to adsorb the phage.
6. Add
5 mlof
the P4-C117 (1.2 OD) mixture to each
1 L of CMLB in a 2.8 L Flask without plug.
7. Incubate at 37°C with vigorous shaking.
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8. Check the OD^,, every 30 min to monitor the lysis
the cells.
A sharp drop of OD (a difference
0.1) indicates the lysis of the cells. (The
could be checked after 3 hours of culture and
should be about 0.5.)
9. When lysis begin, add 10 ml of 0.5 M EGTA pH 8.0
each 1 L of culture to prevent the phage
readsorption.
10. Continue incubation for 1 hour and add 2 ml of
chloroform to the culture.
11. Incubate for 20 min to complete lysis.

of
of
OD
it
to

c> Isolation of P4 Phage from the lysed culture
1. Centrifuge the culture at 17,000 xg at 4°C for 20
min to remove the cell debris. ( 10 K rpm for JA-10
or 11 K rpm for JA-14). Be careful not to decant
the chloroform into the centrifuge bottles.
2. Collect the supernatant and kept on ice. Measure
the total volume.
3. Add PEG 8000 (125 g in 150 ml of H20, dissolved by
heating in microwave oven) to 10 %, NaCl to 0.5 M
(37 g) and 2.5 g of MgCl2. Completely dissolve the
solids with slow stirring.
4. Allow the precipitation to occur overnight at 4°C.
Day 3:
1. Centrifuge at 17,000 xg at 4°C for 30 min.
2. Pour off the supernatant and collect the pellet.
3. Suspend the pellet in 6 ml of P4 diluent and
centrifuge at 17,000 xg for 30 min.
4. Collect the supernatant and repeat step 3 twice,
being careful to keep the pellet from the
supernatant.
5. Combine the supernatants and add CsCl to density cf
1.42.
(Refractive Index = 1.3745 to 1.3755)
6. Ultracentrifuge in 60Ti rotor 60 K rpm for 16 hours
at 8°C. (VTi 65 at 65 K rpm for at least 5 hours)
Day 4:
1. Two milky colored bands should be seen at the one
third away from the top and bottom of the tubes.
2. Collect the top (P4 mature phage) and the bottom
(P4 Head) bands separately using 5 ml syringe with
20 G needle.
3. Add at least 5 times of the P4 diluent to the P4
phage and P4 head and centrifuge to pellet the
phage. (60 K rpm for 2 hours in 60 Ti rotor or 25
K rpm for 4 hours in SW 27 rotor.)
4. Pour off the supernatant and collect the pellet.
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5. To the P4 phage, add 0.5 ml of P4 diluent and keep
on ice overnight to completely dissolve the phage.
Measure the OD260 and adjust to OD = 10. Store the
phage in dark at 4°C.
6. To the P4 Head, suspend in total of 1 to 4 ml of TS
pH 8.0 and transfer to a 15 ml COREX tube for the
P4 DNA.
d> Isolation of P4 Knotted DNA
1. Add equal volume of TS (Tris-NaCl) saturated
phenol, cover with parafilm and invert several
times or vortex.
2. Centrifuge at 4000 rpm in JA-20 rotor for 15 min.
3. Transfer the top aqueous layer to another CORVEX
tube and repeat step 1 and 2.
4. Collect the aqueous layer and add equal volume of
water saturated ether, mix with a pasteur pipet and
let stand for 5 min.
5. Remove the top ether layer.
6. Repeat step 4 and 5 three times.
(operate under
the hood)
7. Add 2 volume of 95% ethanol and cover with the
parafilm. Mix by inverting and keep under -20°C
overnight.
Day 5:
1. Centrifuge at 0°C for 30 min.
2. Collect the pellets and remove the residual
ethanol.
3. Resuspend the DNA in TE buffer.
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APPENDIX II. PROTOCOL FOR PURIFICATION OF MITOCHONDRIAL DNA
TOPOISOMERASE I.
A. PREPARATION OF MITOPLASTS FROM CALF LIVER
1. Trim the fat and grind the fresh calf

liver.

2. Suspendthe ground material in 6 volumes (W/V) of IX MIB
and blend in a blender with a 10 seconds on and off bursts
twice.
3. Centrifuge at 2000 xg for 30 minutes.
JA-14, 4000 rpm)

(JA-10, 3500 rpm;

4. Collect the supernatant and centrifuge at 8500 xg for 35
minutes. (JA-10, 7000 rpm; JA-14, 7500 rpm)
5. Collect
IX MIB.

the pellets and homogenize in 6 volumes (V/V)
Centrifuge as in step 4.

of

6. Homogenize in a final volume of 600 ml per Kg of the
liver with IX MIB.
[Crude mitochondria]
7. Apply 80 ml of the crude mitochondrial suspension to a
two-step sucrose gradient composed of 75 ml of 25% sucrose
in TE and 90 ml of 42.5% sucrose in TE in a 250 ml
bottles.
8. Centrifuge at 26,000 g for 75 minutes.
rpm)

(JA-14, 13,000

9. Collect the banded mitochondria at the interface of the
two sucrose layers with a pipet.
10. Dilute with 2 volumes of TE (10 mM Tris/ 0.1 mM EDTA) and
centrifuge at 22,000 g for 20 minutes. (JA-14, 12,000 rpm)
11. Collect the pellets and homogenize in 6 volumes (V/V) of
IX MIB.
[Purified mitochondria]
12. Determine the mitochondrial protein concentration by
BIURET analysis.
13. Add 1 mg of digitonin per 8 mg of mitochondrial protein
and stir occasionally for 15 min on ice.
[Strip outer
membrane]
14. Dilute with 2 volumes of IX MIB.
15. Centrifuge at 10,000 g for 15 minutes.

(JA-14, 8000 rpm)
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16. Collect the pellets and homogenize in 6 volumes (V/V) of
IX MIB.
17. Repeat step 15.
18. Collect the pellets and homogenize in 50 ml per g of the
mitochondrial protein with 0.5X MIB (for Freeze/Thaw) or
50 mM KPi/ 0.1 M KC1/ 15% glycerol (for direct lysis)
(Mitoplast]
B. ISOLATION AND PURIFICATION OF MITOCHONDRIAL DNA
TOPOISOMERASES FROM MITOPLASTS
A. Lysis of the mitoplast and Collection of the supernatant
1. Add Nonidet P40 (NP40) to the mitochondrial suspension
to a final concentration of 1%.
2. Keep on
ice for 30 minutes
and then centrifuge at
110,000 g for 13.5 hours.
(SW27, 25,000 rpm)
3. Collect the supernatant as SI (0.1 M KC1 supernatant)
4. Homogenize the pellet with 25 ml of PiK-1.0 (50 mM KPi
/I.0 M KCl/ 15% glycerol) per g of mitochondrial
protein.
5. Stir for 30 minutes on ice.
6. Centrifuge at 250,000 g for 3 hours.
rpm; SW50.1, 46,000 rpm)

(60 Ti, 57,000

7. Collect the supernatant as S2 (1.0 M KCl supernatant).
8.

Homogenize the pellet with 15 ml of PiK-2.0 (50 mM KPi
/ 2.0 M KCl/ 15% glycerol) per g of mitochondrial
protein.

9. Stir for 30 minutes on ice.
10. Centrifuge at 250,000 g for 3 hours.
rpm; SW50.1, 46,000 rpm)

(60 Ti, 57,000

11. Collect the supernatant as S3 (2.0 M KCl supernatant).
B. Column Chromatography
1. PC Column

(Phosphocellulose Column)

a. Pack 12.5 ml of PC per g of the mitochondrial protein
in PiK-0.3 (50 mM KPi/ 0.3 M KCl/ 15% glycerol).
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b. Dilute the S2 with Pik-0 (50 mM KPi/ 15% glycerol)
[S2:Pik-0 = 3:7] to 0.3 M KCl.
c. Load the diluted sample to the PC column and wash
with 3 column volumes of the PiK-0.3.
d. Elute the column with a gradient of PiK-0.3 to
PiK-1.5 in a total of 10 column volumes.
e. Collect in each fraction one tenth of the column
volume.
f. Topol and/or TopoII assay at 37°C for 15 or 30
minutes.
g. Combine the active fractions with more than 4 U per
Ml. [PC-1]
2. HA Column

(Hydroxylapatite Column)

a. Pack 4 ml of HA per g of the mitochondrial protein in
PiK-0.3 (50 mM KPi/ 0.3 M KCl/ 15% glycerol/ pH 7.8).
b. Dilute the PC-1 with Pik-0 (50 mM KPi/ 15% glycerol/
pH 8.0) to 0.3 M KCl.
[PC-l:Pik-0 = 1:1]
c. Load the diluted sample to the HA column and wash
with 3 column volumes of the PiK-0.3.
d. Wash with 3 column volumes of Pi-200 (200 mM KPi/ 15%
glycerol / pH 7.8)
e. Elute the column with a gradient of Pi-200 to Pi-1000
(1 M KPi/ 15% glycerol/ pH 7.8) in a total of 10
column volumes.
f. Collect in each fraction one tenth of the column
volume.
g. Topol and/or TopoII assay at 37°C for 15 or 30
minutes.
h. Combine the active fractions with more than 4 U per
Ml.
[HA-1]
3. dsDNA-Cellulose Column
a. Pack 1 ml of ds-DNA-C per g of the mitochondrial
protein in Tris-0.1 (50 mM Tris-HCl/ 0.1 M KCl/ 15%
glycerol).
b. Dialyze the HA-1 with at least 200 volumes of
Tris-0.1 for 1 hours twice.
(The dialysis bags must
be dialyzed with cytochrome c before use to prevent
the adsorbing of the proteins to the membranes.)
c. Load the dialyzed sample to the ds-DNA-C column and
wash with 3 column volumes of the Tris-0.1.
d. Elute the column with a gradient of Tris-0.1 to
Tris-0.6 in a total of 10 column volumes.
e. Collect in each fraction one tenth of the column
volume.
f. Topol and/or TopoII assay at 37°C for 15 or 30
minutes.
g. Combine the active fractions with more than 4 U per
Ml. [ds-DNA-1]
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